National Health Act 1953 Determinations under sections 85, 85A and 88 (No. PB 32 of 2005) (Cth)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DETERMINATIONS UNDER SECTIONS 85, 85A AND 88

No. PB 32 of 2005

I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, pursuant to sections 85, 85A and 88 of the National Health Act 1953, hereby make the following Determinations:

These Determinations commence on 1 December 2005.

2. The Determinations (No. PB 25 of 2005) under sections 85, 85A and 88 of the National Health Act 1953 made on 16 September 2005 with effect from 1 October 2005 are repealed.

3. In these Determinations:

“Act” means the National Health Act 1953;

“base-priced drug” means —

(a) in relation to cimetidine hydrochloride or ranitidine hydrochloride (tablet, effervescent, equivalent to 150 mg ranitidine or syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL): cimetidine or famotidine or nizatidine or ranitidine hydrochloride (tablet equivalent to 150 mg ranitidine or tablet equivalent to 300 mg ranitidine); or

(b) in relation to amlodipine besylate or lercanidipine hydrochloride or nifedipine (tablet 20 mg (controlled release)): felodipine or nifedipine (tablet 10 mg or tablet 20 mg or tablet 30 mg (controlled release) or tablet 60 mg (controlled release)); or

(c) in relation to ramipril (capsule 10 mg): captopril or enalapril maleate or fosinopril sodium or lisinopril or perindopril erbumine or quinapril hydrochloride or ramipril (tablet 1.25 mg or tablet 2.5 mg or tablet 5 mg) or trandolapril;

“CFC” means chlorofluorocarbon;

“CFU” means colony forming unit;

“electronic communication” has the meaning given by subsection 5(1) of the Electronic Transactions Act 1999;

“g” means gram;

“I.M.” means intramuscular;

“I.U.” means international unit;

“I.V.” means intravenous;

“kg” means kilogram;

“L” means litre;

“m” means metre;

“Medicare Australia CEO” means the Chief Executive Officer of Medicare Australia;

“mg” means milligram;

“mL” means millilitre;

“mm” means millimetre;

“mmol” means millimole;

“Regulations” means the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act.

4. For the purposes of subsection 85(3) of the Act, where the strength, type of unit, size of unit or other particulars of form are specified in the column headed “Form” in the First or Second Schedule to these Determinations in relation to a drug or medicinal preparation referred to in subsection 85(2) of the Act the name of which is specified in that Schedule, those particulars refer to the form or forms of the drug or medicinal preparation that is or are allowable for the purposes of Part VII of the Act to the effect that the drug or medicinal preparation in that form or in each of those forms is a pharmaceutical benefit when prescribed by a medical practitioner.

4A. For the purposes of subsection 85(3) of the Act, where a form is specified in the column headed “Form” in the Fourth Schedule to these Determinations, that particular refers to the form of a medicinal preparation, which is composed of one or more of the drugs or medicinal preparations specified in Schedule 4 to the Declaration under subsection 85(2) of the Act with or without the addition of one or more of the substances specified in Schedule 5 to that Declaration, that is allowable for the purposes of Part VII of the Act to the effect that the medicinal preparation in that form is a pharmaceutical benefit when prescribed by a medical practitioner.

5. For the purposes of subsection 88(1A) of the Act, where the strength, type of unit, size of unit or other particulars of form are specified in the column headed “Form” in the Third Schedule to these Determinations in relation to a drug or medicinal preparation referred to in subsection 85(2) of the Act the name of which is specified in that Schedule, those particulars refer to the form or forms of the drug or medicinal preparation that is or are allowable for the purposes of Part VII of the Act to the effect that the drug or medicinal preparation in that form or in each of those forms is a pharmaceutical benefit referred to in subsection 88(1A) of the Act for the supply of which a participating dental practitioner is authorised to write a prescription.

6. The purposes set out in the column headed “Purposes” in Part 2 of the First or Second Schedule to these Determinations are the only purposes for which a medical practitioner may prescribe the maximum quantities and numbers of repeats specified in that Part in relation to those pharmaceutical benefits specified in that same Part.

7. The purposes set out in the column headed “Purposes” in Part 2 of the Third Schedule to these Determinations are the only purposes for which a participating dental practitioner may prescribe the maximum quantities specified in that Part in relation to those pharmaceutical benefits specified in that same Part.

8. For the purposes of subsection 85A(2)(c) of the Act, the manner of administration, if any, set out in the column headed “Manner of administration” in relation to a pharmaceutical benefit, the name of which is specified in:

(a) the First or Second Schedule to these Determinations, is the only manner in which a medical practitioner may, in a prescription, direct the pharmaceutical benefit to be administered; or

(b) the Third Schedule to these Determinations, is the only manner in which a participating dental practitioner may, in a prescription, direct the pharmaceutical benefit to be administered.

9. For the purposes of subsection 85A(2)(a) of the Act, the maximum quantity or number of units of a pharmaceutical benefit that may, in one prescription, be directed to be supplied on any one occasion is:

(a) where the name of the pharmaceutical benefit is specified —

(i) in Part 1 of the First Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(ii) in Part 2 of the First Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(iii) in Part 1 of the Second Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(iv) in Part 2 of the Second Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(v) in Part 1 of the Third Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(vi) in Part 2 of the Third Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum quantity” in relation to the pharmaceutical benefit; or

(b) in any other case — the quantity or number, if any, specified in the column headed “Maximum quantity” in the Fourth Schedule to these Determinations in relation to the form of the pharmaceutical benefit.

10. For the purposes of subsection 85A(2)(b) of the Act, the maximum number of occasions, if any, on which the supply of a pharmaceutical benefit may, in one prescription, be directed by a medical practitioner to be repeated is:

(a) where the name of the pharmaceutical benefit is specified —

(i) in Part 1 of the First Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(ii) in Part 2 of the First Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(iii) in Part 1 of the Second Schedule to these Determinations — the quantity or number, if any, specified in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(iv) in Part 2 of the Second Schedule to these Determinations and the pharmaceutical benefit is prescribed in accordance with the provisions of the column headed “Purposes” — the quantity or number, if any, in that Part of the Schedule in the column headed “Maximum number of repeats” in relation to the pharmaceutical benefit; or

(b) in any other case — the number, if any, specified in the column headed “Maximum number of repeats” in the Fourth Schedule to these Determinations in relation to the form of the pharmaceutical benefit.

11. The following purposes are specified in relation to each pharmaceutical benefit the name of which is specified in Part 2 of the First or Second Schedule to these Determinations:

(a) where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;

(b) where a disease or condition is specified in the column headed “Purposes” —

(i) if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or

(ii)if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;

(c) where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose;

(d) where it is specified in the column headed “Purposes” that compliance with authority procedures set out in subparagraph 11(d) is required — that a medical practitioner has submitted to the Medicare Australia CEO a prescription for the supply of the pharmaceutical benefit:

(i) by preparing and signing the prescription:

(A) in a form approved by the Secretary and completed by the medical practitioner in ink in his or her own handwriting; or

(B) in a form, prepared by means of a computer, that is in accordance with the form approved by the Secretary under subsubsubparagraph (A); or

(C) in a form, prepared by means of a computer, approved in writing for the purpose by the Secretary and in the format approved in writing by the Secretary; or

(D) by a method approved in writing by the Secretary; or

(ii)by submitting the prescription by giving the Medicare Australia CEO by telephone, details of the prescription which has been prepared and signed by the medical practitioner in accordance with subsubparagraph (i); or

(iii)where the medical practitioner has attempted to obtain an authorisation by submitting details of the prescription to the Medicare Australia CEO in accordance with subsubparagraph (ii) but has been unable to do so because of a failure or other form of unavailability in the telephone system established by the Medicare Australia CEO for the provision of such authorisations, by submitting the prescription in accordance with the instructions stipulated in an emergency telephone message provided to the medical practitioner by the Medicare Australia CEO; or

(iv)by submitting the prescription by giving the Medicare Australia CEO, by means of an electronic communication of a kind approved in writing by the Medicare Australia CEO, details of the prescription which has been prepared and signed by the medical practitioner in accordance with subsubparagraph (i).

11A. For the purposes of subsubparagraph 11(d)(i), a prescription that has been prepared and signed by the medical practitioner in accordance with that subparagraph is taken to have been submitted by him or her if it is submitted by one of his or her employees.

12. Subject to paragraph 12B, the authorisation of a prescription submitted under subparagraph 11(d) may be made:

(a) if the prescription was submitted in accordance with subsubparagraph 11(d)(i) — by the Medicare Australia CEO signing his or her authorisation of the prescription on it and:

(i) if the Medicare Australia CEO requires the medical practitioner to alter the prescription — by returning it to the medical practitioner for alteration before the medical practitioner gives it to the person in respect of whom it was prepared; or

(ii) in any other case:

(A) by returning it to the medical practitioner; or

(B) by sending it to the person in respect of whom it was prepared; or

(b) if the prescription was submitted in accordance with subsubparagraph 11(d)(ii) — orally, at the time the Medicare Australia CEO is given details of the prescription; or

(c) if the prescription was submitted in accordance with subsubparagraph 11(d)(iv) — by the Medicare Australia CEO sending his or her authorisation, by electronic communication, to the medical practitioner.

12A. If the Medicare Australia CEO authorises a prescription in accordance with subparagraph 12(b) or (c):

(a) the Medicare Australia CEO must tell the medical practitioner, orally or by electronic communication, the number that has been allotted to the authorised prescription; and

(b) the medical practitioner must:

(i) mark that number on the prescription; and

(ii) retain a copy of the prescription for 1 year from the date on which the prescription was authorised.

12B. Notwithstanding paragraph 12, if the prescription was submitted in accordance with subsubparagraph 11(d)(iii), authorisation shall be deemed to have been granted upon completion by the medical practitioner of the prescription in accordance with the instructions stipulated in the emergency telephone message provided to the medical practitioner by the Medicare Australia CEO.

12C. Where a prescription is authorised, or deemed to be authorised, in accordance with paragraph 12, and an authorisation is also granted in accordance with subregulation 13(5) of the Regulations increasing the maximum quantity or number of units of the pharmaceutical benefit that may, in the prescription, be directed to be supplied on any one occasion, or the maximum number of occasions on which the supply of the pharmaceutical benefit may, in the prescription, be directed to be repeated, the authorisation in accordance with paragraph 12 is taken to be for the prescription of the increased quantity, number, or occasions, as the case may be.

13. The following purposes are specified in relation to each pharmaceutical benefit the name of which is specified in Part 2 of the Third Schedule to these Determinations:

(a) where a class of persons is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for the treatment of a person included in that class of persons;

(b) where a disease or condition is specified in the column headed “Purposes” —

(i) if subsubparagraph (ii) does not apply — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in relation to any person; or

(ii) if the disease or condition is specified in relation to a specified class of persons — that the pharmaceutical benefit is to be supplied for the treatment of that disease or condition in a person included in that class of persons;

(c) where a purpose is specified in the column headed “Purposes” — that the pharmaceutical benefit is to be supplied for that purpose.

14. For the purposes of subsection 85(6) of the Act, the name of the manufacturer or the names of manufacturers denoted in accordance with the following table by letters appearing in the column headed “Brand” in the First, Second or Third Schedule to these Determinations in relation to a drug or medicinal preparation the name of which is specified in that Schedule is or are the brand or brands under which the drug or medicinal preparation may be supplied under Part VII of the Act as a pharmaceutical benefit:

Letters

Manufacturer's Name

Letters

Manufacturer's Name

AB	Abbott Australasia Pty Ltd
AD	Amrad Pharmaceuticals Pty Ltd
AE	AFT Pharmaceuticals Pty Limited
AF	Alphapharm Pty Limited
AG	Allergan Australia Pty Ltd
AH	Altana Pharma Pty Ltd
AL	Alphapharm Medical A Division of Alphapharm Pty Limited
AN	Amgen Australia Pty Ltd
AP	AstraZeneca Pty Ltd
AQ	Alcon Laboratories (Australia) Pty Ltd
AS	Aspen Pharmacare Australia Pty Ltd
AV	Aventis Pharma Pty Limited
AW	Arrow Pharmaceuticals Limited
AX	Aventis Pasteur Pty Limited
BC	Bristol Laboratories A Division of Bristol-Myers Squibb Australia Pty Ltd
BD	Biogen Idec Australia Pty Ltd
BF	Bellwether Pharma Limited
BG	Biochemie Australia A Division of Sandoz Pty Ltd
BN	Bayer Australia Limited
BP	British Pharmaceuticals
BQ	Bristol-Myers Squibb Pharmaceuticals A Division of Bristol-Myers Squibb Australia Pty Ltd
BR	B. Braun Australia Pty Ltd
BU	Bausch & Lomb Surgical A Division of Bausch & Lomb (Australia) Pty Ltd
BX	Baxter Healthcare Pty Limited
BY	Boehringer Ingelheim Pty Limited
CH	Chem mart Pty Limited
CO	Chemists' Own Pty Ltd A member of Sigma Group of Companies
CS	CSL Limited
CV	Ciba Vision Australia Pty Ltd
CX	Contact Lens Centre Australia Ltd
DG	Douglas Medication Systems A Division of Douglas Pharmaceuticals Australia Ltd
DK	Dakota Pharmaceuticals A Division of Sanofi-Synthelabo Australia Pty Limited
DP	Douglas Pharmaceuticals Australia Ltd
DR	DiaCare International Pty Ltd
DT	DermaTech Laboratories Pty Ltd
EO	Ego Pharmaceuticals Pty Ltd
EP	EpiPharm Pty Ltd
EX	Essex Laboratories
FA	F.H. Faulding & Co. Limited
FB	Pierre Fabre Medicament Australia Pty Limited
FL	C. B. Fleet Co. (Aust.) Pty Ltd
FM	Fawns and McAllan Pty Ltd A member of Sigma Group of Companies
FP	Ferring Pharmaceuticals Pty Ltd
FR	Charles E. Frosst Division of Merck Sharp & Dohme (Australia) Pty Ltd
GC	GlaxoSmithKline Consumer Healthcare
GD	General Diabetes Services
GK	GlaxoSmithKline Australia Pty Ltd
GP	GP Laboratories A Division of Pfizer Pty Limited
GX	GenRx Pty Ltd
HA	Hamilton Laboratories Pty Ltd
HP	Hoechst Division of Aventis Pharma Pty Limited
HX	Hexal Australia Pty Ltd
IQ	Ioquin A Division of Alcon Laboratories (Australia) Pty Ltd
IT	InterPharma Pty Ltd
JC	Janssen-Cilag Pty Ltd
JT	Johnson & Johnson Pacific Pty Limited
KN	Knoll A Division of Abbott Australasia Pty Ltd
KR	Kenral Division of Pharmacia Australia Pty Limited
KY	Key Pharmaceuticals Pty Ltd
LB	Life Bioscience Pty Ltd
LF	Laboratoires Fournier S.A.
LM	Link Medical Products Pty Ltd
LN	Lennon Healthcare A Division of Aspen Pharmacare Australia Pty Ltd
LU	Lundbeck Australia Pty Ltd
LY	Eli Lilly Australia Pty Limited
MD	Macarthur Research Division of Roche Products Pty Ltd
ME	Menley & James Division of GlaxoSmithKline Australia Pty Ltd
MF	Mundipharma Pty Ltd
MG	McGloins Classic Brands
MK	Merck Sharp & Dohme (Australia) Pty Ltd
ML	Marion Division of Aventis Pharma Pty Limited
MM	3M Pharmaceuticals Australia Pty Ltd
MQ	Merck Pharmaceuticals
MS	Abbott Diagnostics Division (MediSense Products)
MX	Mayne Pharma Pty Ltd
NA	National Diagnostic Products (Aust) Pty Limited
NE	Norgine Pty Limited
NF	FlexPen Products of Novo Nordisk Pharmaceuticals Pty Ltd
NI	InnoLet Products of Novo Nordisk Pharmaceuticals Pty Ltd
NL	NovoLet Products of Novo Nordisk Pharmaceuticals Pty Ltd
NO	Novo Nordisk Pharmaceuticals Pty Ltd
NT	Nestlé Australia Ltd
NU	Nutricia Australia Pty Limited
NV	Novartis Pharmaceuticals Australia Pty Ltd
OA	Orphan Australia Pty Ltd
OR	Organon (Australia) Pty Limited
PC	Pfizer Consumer Healthcare Pty Ltd
PD	Parke Davis Pty Ltd
PE	Pacific EyeCare A Division of Allergan Australia Pty Ltd
PF	Pfizer Pty Limited
PH	Pharmacia Australia Pty Limited
PK	Pharmatel Fresenius Kabi Pty Ltd
PL	Pharmalab
PM	PMC Pharma A Division of AstraZeneca Pty Ltd
PP	Petrus Pharmaceuticals Pty Ltd
PU	Pharmacia & Upjohn Pty Limited
PX	Point of Care Diagnostics Australia Pty Ltd
QM	Qualimed Division of Aventis Pharma Pty Limited
RC	Reckitt Benckiser (Australia) Pty Limited
RD	Roche Diagnostics Australia Pty Ltd
RE	Real-RL Division of GlaxoSmithKline Australia Pty Ltd
RO	Roche Products Pty Ltd
SB	Scientific Hospital Supplies Australia Products
SC	Schering Pty Ltd Australian Subsidiary of Schering AG, Berlin
SE	Servier Laboratories (Aust.) Pty Ltd
SG	Serono Australia Pty Ltd
SH	Schering-Plough Pty Ltd
SI	Sigma Pharmaceuticals Pty Ltd
SJ	Sharpe Laboratories Pty Ltd
SL	SBPA A Division of Sandoz Pty Ltd
SM	Solvay Pharmaceuticals Division of Solvay Biosciences Pty Ltd
SN	Smith & Nephew Healthcare
SU	Sauter Laboratories (Aust.) Pty Ltd
SW	Sanofi-Synthelabo Australia Pty Limited
SY	Schering AG
SZ	Sandoz Pty Ltd
TC	Technostic Consulting Pty Ltd
TH	Richard Thomson Pty Ltd
TM	Technipro Marketing Pty Ltd
TW	Terry White Chemists
UC	UCB Pharma A Division of UCB Australia Pty Ltd
UW	United Works of Pharmaceutical and Dietetic Products, Hungary
VF	Vitaflo Australia Pty Ltd
VT	Valeant Pharmaceuticals Australasia Pty Ltd
WT	Wyeth Consumer Healthcare Pty Ltd
WW	Wm R. Warner
WX	Wyeth Australia Pty Limited
WY	Wyeth Pharmaceuticals Division of Wyeth Australia Pty Limited

Abciximab	I.V. injection 10 mg in 5 mL vial	Injection	3	..	LY
Acamprosate Calcium	Tablet 333 mg (enteric coated)	Oral	180	1	AF
Acarbose	Tablet 50 mg	Oral	90	5	BN
Tablet 100 mg	Oral	90	5	BN
Acetazolamide	Tablet 250 mg	Oral	100	3	SI
Acetylcysteine Sodium	Inhalation solution equivalent to 200 mg acetylcysteine per mL, 5 mL	Inhalation	30	3	BQ
Aciclovir	Tablet 200 mg	Oral	50	..	AF, DP, GK, GX, HX
Tablet 800 mg	Oral	35	..	AF, AW, DP, GK, GX, HX
Eye ointment 30 mg per g, 4.5 g	Application to the eye	1	..	GK
Acitretin	Capsule 10 mg	Oral	100	2	RO
Capsule 25 mg	Oral	100	2	RO
Adalimumab	Injection 40 mg in 0.8 mL pre-filled syringe	Injection	2	3	AB
Adrenaline	I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector	Injection	1	..	CS
I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector	Injection	1	..	CS
Adrenaline Acid Tartrate	Injection equivalent to adrenaline 1 in 1,000, 1 mL	Injection	5	1	AP
Albendazole	Tablet 200 mg	Oral	6	1	GK
Tablet 400 mg	Oral	60	2	GK
Alendronate Sodium	Tablet equivalent to 70 mg alendronic acid	Oral	4	5	AW, MK
Tablet equivalent to 40 mg alendronic acid	Oral	30	5	MK
"Alfaré"	Oral powder 400 g	Oral	8	5	NT
Allopurinol	Tablet 100 mg	Oral	200	2	AF, CH, FM, GX, HX, SI, TW
Tablet 300 mg	Oral	60	2	AF, CH, FM, GX, HX, SI, TW
Alprazolam	Tablet 250 micrograms	Oral	50	..	AF, AW, HX, PH
Tablet 500 micrograms	Oral	50	..	AF, AW, HX, PH
Tablet 1 mg	Oral	50	2	AF, AW, CH, DP, GX, HX, PH, TW
Tablet 2 mg	Oral	50	2	AF, AW, CH, DP, GX, HX, PH, TW
Alteplase	Injection set containing 1 vial 50 mg in 2.333 g dry powder, 1 vial sterile water for injection 50 mL and 1 transfer cannula	Injection	2	..	BY
Aluminium Hydroxide - Dried with Magnesium Hydroxide	Tablet 200 mg-200 mg	Oral	200	5	PC, WW
Aluminium Hydroxide - Dried with Magnesium Hydroxide	Oral suspension 200 mg-200 mg per 5 mL, 500 mL	Oral	2	5	PC, WW
Aluminium Hydroxide - Dried with Magnesium Trisilicate and Magnesium Hydroxide	Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL	Oral	2	5	FM
Amantadine Hydrochloride	Capsule 100 mg	Oral	100	5	NV
Amiloride Hydrochloride	Tablet 5 mg	Oral	100	1	AF
Aminoglutethimide	Tablet 250 mg	Oral	100	5	NV
Amiodarone Hydrochloride	Tablet 100 mg	Oral	30	5	AF, AW, GX, HX, SW
Tablet 200 mg	Oral	30	5	AF, AW, CH, GX, HX, SW, TW
Amisulpride	Tablet 100 mg	Oral	30	5	SW
Tablet 200 mg	Oral	60	5	SW
Tablet 400 mg	Oral	60	5	SW
Oral solution 100 mg per mL, 60 mL	Oral	2	5	SW
Amitriptyline Hydrochloride	Tablet 10 mg	Oral	50	2	AF
Tablet 25 mg	Oral	50	2	AF, MK
Tablet 50 mg	Oral	50	2	AF
Amlodipine Besylate	Tablet equivalent to 5 mg amlodipine	Oral	30	5	PF
Tablet equivalent to 10 mg amlodipine	Oral	30	5	PF
Amoxycillin Trihydrate	Tablet, chewable, equivalent to 250 mg amoxycillin	Oral	20	1	GK
Tablet equivalent to 1 g amoxycillin	Oral	14	1	BG, GK, SZ
Capsule equivalent to 250 mg amoxycillin	Oral	20	1	AF, CH, CS, DG, DP, GK, GX, HX, SI, TW
Capsule equivalent to 500 mg amoxycillin	Oral	20	1	AF, CH, CS, DG, DP, GK, GX, HX, SI, TW
Sachet containing oral powder equivalent to 3 g amoxycillin	Oral	1	..	GK
Amoxycillin Trihydrate with Potassium Clavulanate	Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid	Oral	10	1	AL, AW, GK, HX, SL, SZ
Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid	Oral	10	1	AL, AW, CH, GK, GX, HX, SL, SZ, TW
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP	Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL	Oral	1	1	AL, AW, GK, HX
Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL	Oral	1	1	AL, AW, GK, HX
Amoxycillin Trihydrate with Water - Purified BP	Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL	Oral	1	1	GK
Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL	Oral	1	1	AF, CH, CS, DP, GK, GX, HX, SI, TW
Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL	Oral	1	1	AF, CH, CS, DP, GK, GX, HX, SI, TW
Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL	Oral	1	1	SZ
Amphotericin	Lozenge 10 mg	Oral	20	1	BQ
Powder for injection 50 mg	Injection	1	..	BQ
Ampicillin Sodium	Powder for injection equivalent to 500 mg ampicillin	Injection	5	1	CS, DP
Powder for injection equivalent to 1 g ampicillin	Injection	5	1	AS, CS, DP
Ampicillin Trihydrate	Capsule equivalent to 250 mg ampicillin	Oral	24	1	AF
Capsule equivalent to 500 mg ampicillin	Oral	24	..	AF
Anakinra	Injection 100 mg in 0.67 mL single use pre-filled syringe	Injection	28	3	AN
Anastrozole	Tablet 1 mg	Oral	30	2	AP
Apraclonidine Hydrochloride	Eye drops equivalent to 5 mg apraclonidine per mL, 10 mL	Application to the eye	1	2	AQ
Aprepitant	Pack containing 1 capsule 125 mg and 2 capsules 80 mg	Oral	1	..	MK
Aripiprazole	Tablet 10 mg	Oral	30	5	BQ
Tablet 15 mg	Oral	30	5	BQ
Tablet 20 mg	Oral	30	5	BQ
Tablet 30 mg	Oral	30	5	BQ
Aspirin	Tablet 100 mg	Oral	112	1	FA, MX
Tablet, dispersible, 300 mg	Oral	96	1	RC
Atenolol	Tablet 50 mg	Oral	30	5	AF, AP, CH, DP, GX, HX, SI, TW
Atorvastatin Calcium	Tablet equivalent to 10 mg atorvastatin	Oral	30	5	PF
Tablet equivalent to 20 mg atorvastatin	Oral	30	5	PF
Tablet equivalent to 40 mg atorvastatin	Oral	30	5	PF
Tablet equivalent to 80 mg atorvastatin	Oral	30	5	PF
Atovaquone	Oral suspension 750 mg per 5 mL, 210 mL	Oral	1	..	GK
Atropine Sulfate	Injection 600 micrograms in 1 mL ampoule	Injection	10	1	AP
Eye drops 10 mg per mL, 15 mL	Application to the eye	1	2	SI
Auranofin	Tablet 3 mg	Oral	60	5	LM
Azathioprine	Tablet 25 mg	Oral	100	2	GK, HX
Tablet 50 mg	Oral	100	2	AF, AW, DP, GK, GX, HX
Azithromycin Dihydrate	Tablet equivalent to 500 mg azithromycin	Oral	2	..	PF
Azithromycin Dihydrate with Water - Purified BP	Powder for oral suspension equivalent to 200 mg azithromycin per 5 mL, 15 mL	Oral	1	..	PF
Baclofen	Tablet 10 mg	Oral	100	5	AF, AW, CH, DP, GX, HX, NV, TW
Tablet 25 mg	Oral	100	5	AF, AW, CH, DP, GX, HX, NV, TW
Balsalazide Sodium	Capsule 750 mg	Oral	180	5	PK
"BCG Immunotherapeutic" (Bacillus Calmette-Guérin/ Connaught strain)	Single dose set comprising 1 vial powder for intravesical administration containing 6.6 to 19.2 x 108 CFU and 1 vial diluent 3 mL	Intravesical administration	3	1	AV
"BCG-Tice" (Bacillus Calmette-Guérin/ Tice strain)	Vial containing powder for intravesical administration approximately 5 x 108 CFU	Intravesical administration	3	1	OR
Beclomethasone Dipropionate	Pressurised inhalation 50 micrograms per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	1	5	MM
Pressurised inhalation 100 micrograms per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	1	5	MM
Pressurised inhalation in breath actuated device 50 micrograms per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	1	5	MM
Pressurised inhalation in breath actuated device 100 micrograms per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	1	5	MM
Benzathine Penicillin	Injection 900 mg in 2 mL cartridge-needle unit (for use with Tubex Injector)	Injection	1	..	AS
Benzhexol Hydrochloride	Tablet 2 mg	Oral	200	2	SI
Tablet 5 mg	Oral	200	1	SI
Benztropine Mesylate	Tablet 2 mg	Oral	60	2	PL
Injection 2 mg in 2 mL ampoule	Injection	5	..	MK
Benzydamine Hydrochloride	Mouth and throat rinse 22.5 mg per 15 mL, 500 mL	Oral application	1	1	MM
Benzyl Benzoate	Application 50 g in 200 mL	Application	1	2	MG
Benzylpenicillin Sodium	Powder for injection equivalent to 600 mg benzylpenicillin	Injection	10	1	CS
Powder for injection equivalent to 3 g benzylpenicillin	Injection	10	..	CS
Betamethasone Acetate with Betamethasone Sodium Phosphate	Injection 3 mg-3.9 mg in 1 mL ampoule	Injection	5	..	SH
Betamethasone Dipropionate	Cream equivalent to 500 micrograms betamethasone per g, 15 g	Application	1	1	EX, SH
Ointment equivalent to 500 micrograms betamethasone per g, 15 g	Application	1	1	EX, SH
Betamethasone Valerate	Cream equivalent to 200 micrograms betamethasone per g, 100 g	Application	2	..	EX, FM, SH, SI
Cream equivalent to 500 micrograms betamethasone per g, 15 g	Application	1	1	FM, SI
Ointment equivalent to 200 micrograms betamethasone per g, 100 g	Application	2	..	EX, SH
Ointment equivalent to 500 micrograms betamethasone per g, 15 g	Application	1	1	FM, SI
Betaxolol Hydrochloride	Eye drops, suspension, equivalent to 2.5 mg betaxolol per mL, 5 mL	Application to the eye	1	5	AQ
Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL	Application to the eye	1	5	AQ, IQ
Bethanechol Chloride	Tablet 10 mg	Oral	100	2	HA
Bicalutamide	Tablet 50 mg	Oral	28	5	AP
Bimatoprost	Eye drops 300 micrograms per mL, 3 mL	Application to the eye	1	5	AG
Biperiden Hydrochloride	Tablet 2 mg	Oral	200	2	AB
Bisacodyl	Tablet 5 mg	Oral	200	2	AE, AS
Suppositories 10 mg, 10	Rectal	3	5	BY, PP
Suppositories 10 mg, 12	Rectal	3	4	FL, PP
Enemas 10 mg in 5 mL, 25	Rectal	1	2	AS
Bisoprolol Fumarate	Tablet 2.5 mg	Oral	28	5	AL
Tablet 5 mg	Oral	28	5	AL
Tablet 10 mg	Oral	28	5	AL
Bivalirudin Trifluoroacetate	Powder for I.V. injection equivalent to 250 mg bivalirudin, vial	Injection	1	..	CS
Bleomycin Sulfate	Powder for injection 15,000 I.U.	Injection	10	..	BQ, MX, SI
Brimonidine Tartrate	Eye drops 2 mg per mL, 5 mL	Application to the eye	1	5	AG, PE
Brimonidine Tartrate with Timolol Maleate	Eye drops 2 mg brimonidine tartrate with timolol maleate equivalent to 5 mg timolol per mL, 5 mL	Application to the eye	1	5	AG
Brinzolamide	Eye drops 10 mg per mL, 5 mL	Application to the eye	1	5	AQ, IQ
Bromocriptine Mesylate	Tablet equivalent to 2.5 mg bromocriptine	Oral	30	..	AF, HX, NV
Capsule equivalent to 5 mg bromocriptine	Oral	60	5	AF, HX, NV
Capsule equivalent to 10 mg bromocriptine	Oral	100	5	AF, NV
Budesonide	Nebuliser suspension 500 micrograms in 2 mL single dose units, 30	Inhalation	1	5	AP
Nebuliser suspension 1 mg in 2 mL single dose units, 30	Inhalation	1	5	AP
Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses	Inhalation by mouth	1	5	AP
Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses	Inhalation by mouth	1	5	AP
Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses	Inhalation by mouth	1	5	AP
Budesonide with Eformoterol Fumarate Dihydrate	Powder for oral inhalation in breath actuated device 100 micrograms-6 micrograms per dose, 120 doses	Inhalation by mouth	1	5	AP
Powder for oral inhalation in breath actuated device 200 micrograms-6 micrograms per dose, 120 doses	Inhalation by mouth	1	5	AP
Powder for oral inhalation in breath actuated devices 400 micrograms-12 micrograms per dose, 60 doses, 2	Inhalation by mouth	1	5	AP
Buprenorphine	Transdermal patch 5 mg	Transdermal	2	..	MF
Transdermal patch 10 mg	Transdermal	2	..	MF
Transdermal patch 20 mg	Transdermal	2	..	MF
Bupropion Hydrochloride	Tablet 150 mg (sustained release)	Oral	30	..	GK
Busulfan	Tablet 2 mg	Oral	100	..	GK
Cabergoline	Tablet 500 micrograms	Oral	2	..	PH
Tablet 1 mg	Oral	30	5	PU
Tablet 2 mg	Oral	30	5	PU
Tablet 4 mg	Oral	30	5	PU
Calcipotriol	Ointment 50 micrograms per g, 30 g	Application	1	1	CS
Calcitriol	Capsule 0.25 microgram	Oral	100	3	AF, AW, DP, GX, HX, RO
Calcium Carbonate	Tablet, chewable, 1.25 g (equivalent to 500 mg calcium)	Oral	120	1	MM
Tablet 1.5 g (equivalent to 600 mg calcium)	Oral	120	1	WT
Calcium Citrate	Tablet equivalent to 250 mg calcium	Oral	120	1	KY
Calcium Folinate	Tablet equivalent to 15 mg folinic acid	Oral	10	..	MX
Injection equivalent to 50 mg folinic acid in 5 mL	Injection	5	5	MX, PF
Injection equivalent to 100 mg folinic acid in 10 mL	Injection	10	1	PF
Candesartan Cilexetil	Tablet 4 mg	Oral	30	5	AP
Tablet 8 mg	Oral	30	5	AP
Tablet 16 mg	Oral	30	5	AP
Candesartan Cilexetil with Hydrochlorothiazide	Tablet 16 mg-12.5 mg	Oral	30	5	AP
Capecitabine	Tablet 150 mg	Oral	60	2	RO
Tablet 500 mg	Oral	120	2	RO
"Caprilon"	Oral powder 420 g	Oral	8	5	SB
Captopril	Tablet 12.5 mg	Oral	90	5	AF, BQ, CH, DP, FM, GX, HX, TW
Tablet 25 mg	Oral	90	5	AF, BQ, CH, DP, FM, GX, HX, TW
Tablet 50 mg	Oral	90	5	AF, BQ, CH, DP, FM, GX, HX, TW
Oral solution 5 mg per mL, 95 mL	Oral	1	5	BQ
Carbachol	Eye drops 15 mg per mL, 15 mL	Application to the eye	1	5	AQ
Eye drops 30 mg per mL, 15 mL	Application to the eye	1	5	AQ
Carbamazepine	Tablet 100 mg	Oral	200	2	BG, NV, SZ
Tablet 200 mg	Oral	200	2	AF, BG, NV, SZ
Tablet 200 mg (controlled release)	Oral	200	2	NV
Tablet 400 mg (controlled release)	Oral	200	2	NV
Oral suspension 100 mg per 5 mL, 300 mL	Oral	1	5	NV
Carbimazole	Tablet 5 mg	Oral	200	2	RO
"Carbohydrate Free Mixture"	Oral powder 225 g	Oral	24	5	SB
Carbomer 974	Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30	Application to the eye	3	5	AQ
Carbomer 980	Ocular lubricating gel 2 mg per g, 10 g	Application to the eye	1	5	BU, CV, NV
Eye drops 2 mg per g, single dose units 0.6 mL, 30	Application to the eye	3	5	NV
Carboplatin	Solution for I.V. injection 50 mg in 5 mL vial	Injection	2	..	MX, PU
Solution for I.V. injection 150 mg in 15 mL vial	Injection	6	..	MX, PU
Solution for I.V. injection 450 mg in 45 mL vial	Injection	2	..	MX, PU
Carmellose Sodium	Eye drops 5 mg per mL, 15 mL	Application to the eye	1	5	AG
Eye drops 10 mg per mL, 15 mL	Application to the eye	1	5	AG
Eye drops 2.5 mg per mL, single dose units 0.6 mL, 24	Application to the eye	4	5	CX
Eye drops 5 mg per mL, single dose units 0.4 mL, 30	Application to the eye	3	5	AG
Eye drops 10 mg per mL, single dose units 0.4 mL, 30	Application to the eye	3	5	AG
Ocular lubricating gel 10 mg per mL, single dose units 0.6 mL, 28	Application to the eye	3	5	CX
Carvedilol	Pack containing 30 tablets 3.125 mg, 30 tablets 6.25 mg and 10 tablets 12.5 mg	Oral	1	..	RO
Tablet 3.125 mg	Oral	30	..	MD, RO
Tablet 6.25 mg	Oral	60	5	MD, RO
Tablet 12.5 mg	Oral	60	5	MD, RO
Tablet 25 mg	Oral	60	5	MD, RO
Cefaclor Monohydrate	Tablet (sustained release) equivalent to 375 mg cefaclor	Oral	10	1	AF, AS, CH, DG, DP, GX, LN, TW
Cefaclor Monohydrate with Water - Purified BP	Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL	Oral	1	1	AF, AS, AW, CH, GX, TW
Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL	Oral	1	1	AF, AS, AW, CH, GX, TW
Cefepime Hydrochloride	Powder for injection equivalent to 1 g cefepime	Injection	10	..	BQ
Powder for injection equivalent to 2 g cefepime	Injection	10	..	BQ
Cefotaxime Sodium	Powder for injection equivalent to 1 g cefotaxime	Injection	10	..	MX, SZ
Powder for injection equivalent to 2 g cefotaxime	Injection	10	..	MX, SZ
Ceftriaxone Sodium	Powder for injection equivalent to 250 mg ceftriaxone	Injection	1	..	RO
Powder for injection equivalent to 500 mg ceftriaxone	Injection	5	..	RO
Powder for injection equivalent to 1 g ceftriaxone	Injection	5	..	MX, RO, SZ
Powder for injection equivalent to 2 g ceftriaxone	Injection	5	..	MX, RO, SZ
Cefuroxime Axetil	Tablet equivalent to 250 mg cefuroxime	Oral	14	1	GK
Celecoxib	Capsule 100 mg	Oral	60	3	PH
Capsule 200 mg	Oral	30	3	PH
Cephalexin	Capsule 250 mg (anhydrous)	Oral	20	1	AF, AS, CH, DP, GX, HX, LN, TW
Capsule 500 mg (anhydrous)	Oral	20	1	AF, AS, CH, DP, GX, HX, LN, TW
Cephalexin with Water - Purified BP	Granules for oral suspension 125 mg per 5 mL, 100 mL	Oral	1	1	AF, AS, CH, DP, GX, LN, TW
Granules for oral suspension 250 mg per 5 mL, 100 mL	Oral	1	1	AF, AS, CH, DP, GX, LN, TW
Cephalothin Sodium	Powder for injection equivalent to 1 g cephalothin	Injection	10	1	LY, MX
Cephazolin Sodium	Powder for injection equivalent to 500 mg cephazolin	Injection	10	..	MX
Powder for injection equivalent to 1 g cephazolin	Injection	10	..	LY, MX, SZ
Chlorambucil	Tablet 2 mg	Oral	100	2	GK
Chloramphenicol	Ear drops (aqueous) 5 mg per mL, 5 mL	Application to the ear	1	2	PF
Eye drops 5 mg per mL, 10 mL	Application to the eye	1	2	PF, SI
Eye ointment 10 mg per g, 4 g	Application to the eye	1	..	PF, SI
Chlorpromazine Hydrochloride	Tablet 10 mg	Oral	100	5	AV
Tablet 25 mg	Oral	100	5	AV
Tablet 100 mg	Oral	100	5	AV
Oral solution 25 mg per 5 mL, 100 mL	Oral	1	5	AV
Injection 50 mg in 2 mL ampoule	Injection	10	..	AV
Chlorthalidone	Tablet 25 mg	Oral	100	1	NV
Cholestyramine	Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50	Oral	2	5	BQ
Sachets containing 9.4 g oral powder (equivalent to 8 g cholestyramine), 50	Oral	1	5	BQ
Chorionic Gonadotrophin	Injection set containing 3 ampoules powder for injection 500 units and 3 ampoules solvent 1 mL	Injection	1	5	OR
Injection set containing 3 ampoules powder for injection 1,500 units and 3 ampoules solvent 1 mL	Injection	1	5	OR
Ciclesonide	Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	AH
Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	AH
Cimetidine	Tablet 200 mg	Oral	120	5	AF, GK, HX
Tablet 400 mg	Oral	60	5	AF, GK, GX, HX
Tablet 800 mg	Oral	30	5	AF, GK, GX, HX
Cimetidine Hydrochloride	Tablet, effervescent, equivalent to 800 mg cimetidine	Oral	30	5	GK
Ciprofloxacin Hydrochloride	Tablet equivalent to 500 mg ciprofloxacin	Oral	14	..	AL, AW, BG, BN, DP, GX, HX
Tablet equivalent to 750 mg ciprofloxacin	Oral	14	..	AL, AW, BN, DP, GX, HX
Tablet equivalent to 250 mg ciprofloxacin	Oral	2	..	BN
Eye drops equivalent to 3 mg ciprofloxacin per mL, 5 mL	Application to the eye	2	..	AQ, IQ
Cisplatin	I.V. injection 10 mg in 10 mL vial	Injection	1	..	PU
I.V. injection 50 mg in 50 mL vial	Injection	1	..	MX, PU
I.V. injection 100 mg in 100 mL vial	Injection	1	..	MX
Citalopram Hydrobromide	Tablet equivalent to 10 mg citalopram	Oral	28	5	AF
Tablet equivalent to 20 mg citalopram	Oral	28	5	AF, AW, CH, DP, GX, HX, LU, TW
Tablet equivalent to 40 mg citalopram	Oral	28	5	AF, GX, HX
Cladribine	Injection 10 mg in 5 mL vial	Injection	7	..	OA
Solution for I.V. infusion 10 mg in 10 mL single use vial	Injection	7	..	JC
Clarithromycin	Tablet 250 mg	Oral	14	1	AB, AF, CH, DP, GX, HX, TW
Clindamycin Hydrochloride	Capsule equivalent to 150 mg clindamycin	Oral	25	..	KR, PH
Clomiphene Citrate	Tablet 50 mg	Oral	10	5	AV, AW, GX, HX, SG
Clomipramine Hydrochloride	Tablet 25 mg	Oral	50	2	AF, CH, GX, NV, TW
Clonazepam	Tablet 500 micrograms	Oral	200	2	AF, RO
Tablet 2 mg	Oral	200	2	AF, RO
Oral liquid 2.5 mg per mL, 10 mL	Oral	2	..	RO
Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)	Injection	5	..	RO
Clonidine Hydrochloride	Tablet 100 micrograms	Oral	100	5	BY
Tablet 150 micrograms	Oral	100	5	BY
Clopidogrel Hydrogen Sulfate	Tablet equivalent to 75 mg clopidogrel	Oral	28	5	BQ, SW
Coal Tar - Prepared	Gel 10 mg per g, 100 mL	Application	1	2	EP
Codeine Phosphate	Tablet 30 mg	Oral	20	..	FM
Codeine Phosphate with Paracetamol	Tablet 30 mg-500 mg	Oral	20	..	AL, CO, DK, FM, GK, SW
Colchicine	Tablet 500 micrograms	Oral	100	2	AS, LN
Colestipol Hydrochloride	Oral powder, sachets 5 g, 120	Oral	1	5	PH
Copper Sulfate	Tablets, diagnostic compound, 36	2	3	BN
Cortisone Acetate	Tablet 5 mg	Oral	50	4	AS
Tablet 25 mg	Oral	60	4	AS
Cyclophosphamide	Tablet 50 mg	Oral	50	2	PH
Powder for injection 500 mg (anhydrous)	Injection	2	..	BX
Powder for injection 1 g (anhydrous)	Injection	1	..	BX
Powder for injection 2 g (anhydrous)	Injection	1	..	BX
Cyclosporin	Capsule 10 mg	Oral	120	3	NV
Capsule 25 mg	Oral	60	3	HX, MX, NV
Capsule 50 mg	Oral	60	3	HX, MX, NV
Capsule 100 mg	Oral	60	3	HX, MX, NV
Oral liquid 100 mg per mL, 50 mL	Oral	2	3	NV
Cyproheptadine Hydrochloride	Tablet 4 mg (anhydrous)	Oral	100	2	FR
Cyproterone Acetate	Tablet 50 mg	Oral	20	5	AF, DP, GX, HX, SC, SY
Tablet 100 mg	Oral	50	5	DP, GX, HX, SC, SY
Cytarabine	Injection 100 mg in 5 mL vial	Injection	10	1	PU
Injection 500 mg in 5 mL vial	Injection	2	1	MX
Dalteparin Sodium	Injection 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe	Injection	10	1	PH
Injection 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe	Injection	10	1	PH
Injection 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe	Injection	10	1	PH
Injection 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe	Injection	10	1	PH
Danazol	Capsule 100 mg	Oral	100	5	AF
Capsule 200 mg	Oral	100	5	AF
Dantrolene Sodium	Capsule 25 mg	Oral	100	2	PU
Capsule 50 mg	Oral	100	2	PU
Dapsone	Tablet 25 mg	Oral	100	1	LM
Tablet 100 mg	Oral	100	1	LM
Desmopressin Acetate	Intranasal solution 100 micrograms per mL, 2.5 mL dropper bottle	Nasal	5	5	FP
Tablet 200 micrograms	Oral	30	5	FP
Nasal spray (pump pack) 10 micrograms per actuation, 60 actuations, 6 mL	Nasal	1	5	FP
Dexamethasone	Tablet 500 micrograms	Oral	30	4	AS
Tablet 4 mg	Oral	30	4	AS
Eye drops 1 mg per mL, 5 mL	Application to the eye	1	2	AQ
Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin	Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL	Application to the ear	1	2	AV, QM
Dexamethasone Sodium Phosphate	Injection equivalent to 4 mg dexamethasone phosphate in 1 mL ampoule	Injection	5	..	MX
Injection equivalent to 8 mg dexamethasone phosphate in 2 mL vial	Injection	5	1	MX
Injection equivalent to 120 mg dexamethasone phosphate in 5 mL vial	Injection	1	..	MX
Dexamphetamine Sulfate	Tablet 5 mg	Oral	100	5	SI
"Dialamine"	Oral powder 200 g	Oral	10	5	SB
Diazepam	Tablet 2 mg	Oral	50	..	AF, AW, RO, SU
Tablet 5 mg	Oral	50	..	AF, AW, DP, RO, SU
Injection 10 mg in 2 mL ampoule	Injection	5	..	MX
Diclofenac Sodium	Tablet 25 mg (enteric coated)	Oral	100	3	AF, AW, BG, CH, DP, GX, HX, NV, TW
Tablet 50 mg (enteric coated)	Oral	50	3	AF, AW, CH, DP, GX, HX, NV, TW
Eye drops 1 mg per mL, 5 mL	Application to the eye	1	..	NV
Suppository 100 mg	Rectal	40	3	NV
Dicloxacillin Sodium	Capsule equivalent to 250 mg dicloxacillin	Oral	24	..	AF, BQ, SI
Capsule equivalent to 500 mg dicloxacillin	Oral	24	..	AF, BQ, SI
Powder for injection equivalent to 500 mg dicloxacillin	Injection	5	..	BQ
Powder for injection equivalent to 1 g dicloxacillin	Injection	5	1	BQ
Diflunisal	Tablet 250 mg	Oral	100	3	MK
Tablet 500 mg	Oral	50	3	MK
"Digestelact"	Oral powder 900 g	Oral	3	1	SJ
Digoxin	Tablet 62.5 micrograms	Oral	200	1	FM, SI
Tablet 250 micrograms	Oral	100	1	FM, SI
Paediatric oral solution 50 micrograms per mL, 60 mL	Oral	2	3	SI
Dihydroergotamine Mesylate	Injection 1 mg in 1 mL ampoule	Injection	5	..	NV
Diltiazem Hydrochloride	Tablet 60 mg	Oral	90	5	AF, AV, CH, DP, GX, HP, HX, TW
Capsule 180 mg (controlled delivery)	Oral	30	5	AV, CH, DP, GX, HP, TW
Capsule 240 mg (controlled delivery)	Oral	30	5	AV, CH, DP, GX, HP, TW
Capsule 360 mg (controlled delivery)	Oral	30	5	AV, HP
Diphenoxylate Hydrochloride with Atropine Sulfate	Tablet 2.5 mg-25 micrograms	Oral	20	..	KR, PH
Diphtheria and Tetanus Vaccine - Adsorbed	Injection 0.5 mL ampoule	Injection	3	..	CS
Diphtheria and Tetanus Vaccine - Adsorbed (Diluted)	Injection 0.5 mL in pre-filled syringe. For immunisation of adults and children over the age of 8 years	Injection	3	..	CS
Dipivefrine Hydrochloride	Eye drops 1 mg per mL, 10 mL	Application to the eye	1	5	AG
Dipyridamole	Capsule 200 mg (sustained release)	Oral	60	5	BY
Dipyridamole with Aspirin	Capsule 200 mg (sustained release)-25 mg	Oral	60	5	BY
Disodium Etidronate	Tablet 200 mg	Oral	60	5	PU
Disodium Etidronate and Calcium Carbonate	Pack containing 28 tablets disodium etidronate 200 mg and 76 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium)	Oral	1	1	PU
Disodium Pamidronate	Concentrated injection 15 mg in 5 mL vial	Injection	4	..	MX
Injection set containing 4 vials powder for I.V. infusion 15 mg and 4 ampoules solvent 5 mL	Injection	1	..	NV
Concentrated injection 30 mg in 10 mL vial	Injection	2	..	MX
Injection set containing 2 vials powder for I.V. infusion 30 mg and 2 ampoules solvent 10 mL	Injection	1	..	NV
Concentrated injection 60 mg in 10 mL vial	Injection	1	..	MX
Disopyramide	Capsule 100 mg	Oral	100	5	AV
Capsule 150 mg	Oral	100	5	AV
Docetaxel	Injection set containing 1 single use vial concentrate for I.V. infusion 20 mg (anhydrous) in 0.5 mL and 1 single use vial solvent 1.5 mL	Injection	2	..	AV
Injection set containing 1 single use vial concentrate for I.V. infusion 80 mg (anhydrous) in 2 mL and 1 single use vial solvent 6 mL	Injection	1	..	AV
Docusate Sodium with Bisacodyl	Suppositories 100 mg-10 mg, 5	Rectal	6	5	FM
Dolasetron Mesylate	Tablet 200 mg	Oral	2	..	AV
I.V. injection 100 mg in 5 mL ampoule	Injection	1	..	AV
Domperidone	Tablet 10 mg	Oral	25	..	JC
Donepezil Hydrochloride	Tablet 5 mg	Oral	28	5	PF
Tablet 10 mg	Oral	28	5	PF
Dorzolamide Hydrochloride	Eye drops equivalent to 20 mg dorzolamide per mL, 5 mL	Application to the eye	1	5	MK
Dorzolamide Hydrochloride with Timolol Maleate	Eye drops equivalent to 20 mg dorzolamide-5 mg timolol per mL, 5 mL	Application to the eye	1	5	MK
Dothiepin Hydrochloride	Capsule 25 mg	Oral	50	2	AB, AF
Tablet 75 mg	Oral	30	2	AB, AF
Doxepin Hydrochloride	Tablet equivalent to 50 mg doxepin	Oral	50	2	AF
Capsule equivalent to 10 mg doxepin	Oral	50	2	AF, PF
Capsule equivalent to 25 mg doxepin	Oral	50	2	AF, PF
Doxorubicin Hydrochloride	Solution for I.V. injection or intravesical administration 10 mg in 5 mL single dose vial	Injection or intravesical administration	4	..	IT, MX, PH
Solution for I.V. injection or intravesical administration 20 mg in 10 mL single dose vial	Injection or intravesical administration	4	..	PH
Solution for I.V. injection or intravesical administration 50 mg in 25 mL single dose vial	Injection or intravesical administration	3	..	IT, MX, PH
Solution for I.V. injection or intravesical administration 100 mg in 50 mL single dose vial	Injection or intravesical administration	1	..	IT
Solution for I.V. injection or intravesical administration 200 mg in 100 mL single dose vial	Injection or intravesical administration	1	..	IT
Doxorubicin Hydrochloride - Pegylated Liposomal	Suspension for I.V. infusion 20 mg in 10 mL vial	Injection	1	..	SH
Suspension for I.V. infusion 50 mg in 25 mL vial	Injection	1	..	SH
Doxycycline Hydrochloride	Tablet equivalent to 50 mg doxycycline	Oral	25	5	AF, DP, PF
Capsule equivalent to 50 mg doxycycline (containing enteric coated pellets)	Oral	25	5	FA, MX
Tablet equivalent to 100 mg doxycycline	Oral	7	1	AF, DP, PF, SI
Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets)	Oral	7	1	FA, MX
Doxycycline Monohydrate	Tablet equivalent to 50 mg doxycycline	Oral	25	5	AW, CH, GX, HX, TW
Tablet equivalent to 100 mg doxycycline	Oral	7	1	CH, GX, HX, TW
Drotrecogin Alfa (Activated)	Powder for I.V. infusion 5 mg, vial	Injection	1	..	LY
Powder for I.V. infusion 20 mg, vial	Injection	1	..	LY
"Duocal"	Oral powder 400 g	Oral	8	5	SB
Dydrogesterone	Tablet 10 mg	Oral	28	2	SM
"Easiphen"	Oral liquid 250 mL	Oral	90	5	SB
Eformoterol Fumarate Dihydrate	Capsule containing powder for oral inhalation 12 micrograms (for use in Foradile Aerolizer)	Inhalation by mouth	60	5	NV
Powder for oral inhalation in breath actuated device 6 micrograms per dose, 60 doses	Inhalation by mouth	1	5	AP
Powder for oral inhalation in breath actuated device 12 micrograms per dose, 60 doses	Inhalation by mouth	1	5	AP
"EleCare"	Oral powder 400 g	Oral	8	5	AB
Enalapril Maleate	Tablet 5 mg	Oral	30	5	AD, AF, BF, CH, DP, GX, HX, MK, SI, TW
Tablet 10 mg	Oral	30	5	AD, AF, BF, CH, DP, GX, HX, MK, SI, TW
Tablet 20 mg	Oral	30	5	AD, AF, BF, CH, DP, GX, HX, MK, SI, TW
Enalapril Maleate with Hydrochlorothiazide	Tablet 20 mg-6 mg	Oral	30	5	MK
"Energivit"	Oral powder 400 g	Oral	8	5	SB
Enoxaparin Sodium	Injection 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe	Injection	10	1	AV
Injection 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe	Injection	10	1	AV
Injection 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe	Injection	10	1	AV
Injection 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe	Injection	10	1	AV
Injection 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe	Injection	10	1	AV
Entacapone	Tablet 200 mg	Oral	200	4	NV
Epirubicin Hydrochloride	Solution for injection 10 mg in 5 mL	Injection or intravesical administration	4	..	IT, PH
Solution for injection 20 mg in 10 mL	Injection or intravesical administration	4	..	PH
Solution for injection 50 mg in 25 mL	Injection or intravesical administration	3	..	IT, PH
Solution for injection 100 mg in 50 mL	Injection or intravesical administration	2	..	IT
Solution for injection 200 mg in 100 mL	Injection or intravesical administration	1	..	IT
Eprosartan Mesylate	Tablet equivalent to 400 mg eprosartan	Oral	56	5	SM
Tablet equivalent to 600 mg eprosartan	Oral	28	5	SM
Eprosartan Mesylate with Hydrochlorothiazide	Tablet equivalent to 600 mg eprosartan with 12.5 mg hydrochlorothiazide	Oral	28	5	SM
Eptifibatide Acetate	Solution for I.V. injection equivalent to 20 mg eptifibatide in 10 mL vial	Injection	2	..	SH
Solution for I.V. infusion equivalent to 75 mg eptifibatide in 100 mL vial	Injection	3	..	SH
Erythromycin	Capsule 250 mg (containing enteric coated pellets)	Oral	25	1	FA, MX
Erythromycin Ethyl Succinate	Tablet equivalent to 400 mg erythromycin	Oral	25	1	AB, AF
Erythromycin Ethyl Succinate with Water - Purified BP	Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL	Oral	1	1	AB, AF
Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL	Oral	1	1	AB, AF
Erythromycin Lactobionate	Powder for I.V. infusion equivalent to 1 g erythromycin, vial	Injection	5	..	AB
Escitalopram Oxalate	Tablet equivalent to 10 mg escitalopram	Oral	28	5	LU
Tablet equivalent to 20 mg escitalopram	Oral	28	5	LU
Oral solution equivalent to 10 mg escitalopram per mL, 28 mL	Oral	1	5	LU
Esomeprazole Magnesium Trihydrate	Tablet (enteric coated), equivalent to 40 mg esomeprazole	Oral	30	1	AP
Tablet (enteric coated), equivalent to 20 mg esomeprazole	Oral	30	5	AP
Esomeprazole Magnesium Trihydrate and Clarithromycin and Amoxycillin Trihydrate	Pack containing 14 tablets (enteric coated) esomeprazole magnesium trihydrate equivalent to 20 mg esomeprazole, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin	Oral	1	..	AP
Etanercept	Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL	Injection	3	..	WY
Injection set containing 4 vials powder for injection 50 mg and 4 pre-filled syringes solvent 1 mL	Injection	1	3	WY
Ethacrynic Acid	Tablet 25 mg	Oral	200	1	MK
Ethosuximide	Capsule 250 mg	Oral	200	2	PF
Oral solution 250 mg per 5 mL, 200 mL	Oral	1	5	PF
Etonogestrel	Subcutaneous implant 68 mg	Subcutaneous implantation	1	..	OR
Etoposide	Capsule 50 mg	Oral	20	..	BQ
Capsule 100 mg	Oral	10	..	BQ
Solution for I.V. infusion 100 mg in 5 mL vial	Injection	5	..	IT, MX
Etoposide Phosphate	Powder for I.V. infusion 113.6 mg, vial	Injection	5	..	BQ
Powder for I.V. infusion 1.136 g, vial	Injection	1	..	BQ
Everolimus	Tablet 0.25 mg	Oral	60	3	NV
Tablet 0.5 mg	Oral	60	3	NV
Tablet 0.75 mg	Oral	120	3	NV
Exemestane	Tablet 25 mg	Oral	30	2	PH
Ezetimibe	Tablet 10 mg	Oral	30	5	MK
Famciclovir	Tablet 125 mg	Oral	40	1	NV
Tablet 250 mg	Oral	21	..	NV
Famotidine	Tablet 20 mg	Oral	60	5	AF, AW, CH, DP, GX, HX, MK, TW
Tablet 40 mg	Oral	30	5	AF, AW, CH, DP, GX, HX, MK, TW
Felodipine	Tablet 2.5 mg (extended release)	Oral	30	5	AL, AP
Tablet 5 mg (extended release)	Oral	30	5	AL, AP
Tablet 10 mg (extended release)	Oral	30	5	AL, AP
Fenofibrate	Capsule 67 mg	Oral	60	5	LF
Tablet 160 mg	Oral	30	5	LF
Fentanyl	Transdermal patch 2.5 mg	Transdermal	5	..	JC
Transdermal patch 5 mg	Transdermal	5	..	JC
Transdermal patch 7.5 mg	Transdermal	5	..	JC
Transdermal patch 10 mg	Transdermal	5	..	JC
Ferrous Sulfate	Oral liquid 30 mg per mL, 250 mL	Oral	1	2	AE
Flecainide Acetate	Tablet 50 mg	Oral	60	5	MM
Tablet 100 mg	Oral	60	5	AF, MM
Flucloxacillin Magnesium with Water - Purified BP	Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL	Oral	1	..	CS, GK
Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL	Oral	1	..	CS, GK
Flucloxacillin Sodium	Capsule equivalent to 250 mg flucloxacillin	Oral	24	..	AF, CS, GK, SI
Capsule equivalent to 500 mg flucloxacillin	Oral	24	..	AF, CS, GK, SI
Powder for injection equivalent to 500 mg flucloxacillin	Injection	5	..	CS, DP
Powder for injection equivalent to 1 g flucloxacillin	Injection	5	1	AS, CS, DP, MX
Fluconazole	Capsule 50 mg	Oral	28	5	PF
Capsule 100 mg	Oral	28	5	PF
Capsule 200 mg	Oral	28	5	PF
Solution for I.V. infusion 100 mg in 50 mL vial	Injection	7	..	PF
Solution for I.V. infusion 200 mg in 100 mL vial	Injection	7	..	PF
Fludrocortisone Acetate	Tablet 100 micrograms	Oral	200	1	BQ
Fluorometholone	Eye drops 1 mg per mL, 5 mL	Application to the eye	1	5	AG, AQ
Fluorometholone Acetate	Eye drops 1 mg per mL, 5 mL	Application to the eye	1	2	AQ
Fluorouracil Sodium	Injection equivalent to 500 mg fluorouracil in 10 mL vial	Injection	10	..	MX
Fluoxetine Hydrochloride	Tablet, dispersible, equivalent to 20 mg fluoxetine	Oral	28	5	AL, LY
Capsule equivalent to 20 mg fluoxetine	Oral	28	5	AF, AL, BF, CH, DP, GX, HX, LY, SI, TW
Oral solution equivalent to 20 mg fluoxetine per 5 mL, 140 mL	Oral	1	5	AL
Flupenthixol Decanoate	Oily I.M. injection 20 mg in 1 mL ampoule	Injection	5	..	LU
Oily I.M. injection 40 mg in 2 mL ampoule	Injection	5	..	LU
Oily I.M. injection 100 mg in 1 mL ampoule	Injection	5	..	LU
Fluphenazine Decanoate	Injection 12.5 mg in 0.5 mL ampoule	Injection	5	..	BQ
Injection 25 mg in 1 mL ampoule	Injection	5	..	BQ
Injection 50 mg in 2 mL ampoule	Injection	5	..	BQ
Flurbiprofen Sodium	Eye drops 300 micrograms per mL, single dose units 0.4 mL, 5	Application to the eye	1	..	AG
Flutamide	Tablet 250 mg	Oral	100	5	AF, SH
Fluticasone Propionate	Pressurised inhalation 50 micrograms per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	GK
Pressurised inhalation 125 micrograms per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5

Pressurised inhalation 250 micrograms per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	1	GK
Powder for oral inhalation in breath actuated device 100 micrograms per dose, 60 doses	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device 250 micrograms per dose, 60 doses	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device 500 micrograms per dose, 60 doses	Inhalation by mouth	1	1	GK
Fluticasone Propionate with Salmeterol Xinafoate	Pressurised inhalation 50 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	GK
Pressurised inhalation 125 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	GK
Pressurised inhalation 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device 100 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device 500 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses	Inhalation by mouth	1	5	GK
Fluvastatin Sodium	Capsule equivalent to 20 mg fluvastatin	Oral	28	5	AP, NV
Capsule equivalent to 40 mg fluvastatin	Oral	28	5	AP, NV
Fluvoxamine Maleate	Tablet 50 mg	Oral	30	5	AL, AW, HX, SM
Tablet 100 mg	Oral	30	5	AF, AW, HX, SM
Folic Acid	Tablet 500 micrograms	Oral	200	..	AF
Tablet 5 mg	Oral	200	1	AF
Follitropin Alfa	Injection set containing 1 vial powder for injection 75 I.U. and 1 pre-filled syringe solvent 1 mL	Injection	5	5	SG
Injection set containing 10 vials powder for injection 75 I.U. and 10 pre-filled syringes solvent 1 mL	Injection	1	5	SG
Injection 300 I.U. in 0.5 mL multi-dose cartridge	Injection	3	5	SG
Injection set containing 1 vial powder for injection 450 I.U. and 1 pre-filled syringe solvent 1 mL	Injection	3	5	SG
Injection 450 I.U. in 0.75 mL multi-dose cartridge	Injection	3	5	SG
Injection 900 I.U. in 1.5 mL multi-dose cartridge	Injection	2	5	SG
Injection set containing 1 vial powder for injection 1,050 I.U. and 1 pre-filled syringe solvent 2 mL	Injection	1	5	SG
Follitropin Beta	Solution for injection 100 I.U. in 0.5 mL single use vial	Injection	10	5	OR
Solution for injection 150 I.U. in 0.5 mL single use vial	Injection	10	5	OR
Solution for injection 200 I.U. in 0.5 mL single use vial	Injection	10	5	OR
Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge	Injection	3	5	OR
Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge	Injection	2	5	OR
Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge	Injection	2	5	OR
Fondaparinux Sodium	Injection 2.5 mg in 0.5 mL single dose pre-filled syringe	Injection	7	..	GK
Fosinopril Sodium	Tablet 10 mg	Oral	30	5	BQ
Tablet 20 mg	Oral	30	5	BQ
Fosinopril Sodium with Hydrochlorothiazide	Tablet 10 mg-12.5 mg Tablet 20 mg-12.5 mg	Oral Oral	30 30	5 5	BQ BQ
Fotemustine	Powder for injection 208 mg with solvent	Injection	1	4	SE
Framycetin Sulfate	Eye or ear drops 5 mg per mL, 8 mL	Application to the eye or ear	1	2	AV
Frusemide	Tablet 20 mg	Oral	100	1	AV, CH, DP, FM, GX, TW
Tablet 40 mg	Oral	100	1	AF, AV, CH, DP, FM, GX, HX, TW
Tablet 500 mg	Oral	50	3	FM
Oral solution 10 mg per mL, 30 mL	Oral	1	3	AV
Injection 20 mg in 2 mL	Injection	5	..	AV, HX
Gabapentin	Capsule 100 mg	Oral	100	5	AF, AW, PF
Capsule 300 mg	Oral	100	5	AF, AL, AW, DP, GX, HX, MX, PF
Capsule 400 mg	Oral	100	5	AF, AL, AW, DP, GX, HX, MX, PF
Tablet 600 mg	Oral	100	5	PF
Tablet 800 mg	Oral	100	5	AF, AW, PF
Galantamine Hydrobromide	Tablet equivalent to 4 mg galantamine	Oral	56	5	JC
Tablet equivalent to 8 mg galantamine	Oral	56	5	JC
Tablet equivalent to 12 mg galantamine	Oral	56	5	JC
Capsule (prolonged release) equivalent to 8 mg galantamine	Oral	28	5	JC
Capsule (prolonged release) equivalent to 16 mg galantamine	Oral	28	5	JC
Capsule (prolonged release) equivalent to 24 mg galantamine	Oral	28	5	JC
Gefitinib	Tablet 250 mg	Oral	30	1	AP
Gelatin - Succinylated	I.V. infusion 20 g per 500 mL, 500 mL	Injection	3	..	BR
Gemcitabine Hydrochloride	Powder for I.V. infusion equivalent to 200 mg gemcitabine	Injection	4	2	LY
Powder for I.V. infusion equivalent to 1 g gemcitabine	Injection	2	2	LY
Gemfibrozil	Tablet 600 mg	Oral	60	5	AF, CH, DP, GX, HX, PF, SI, TW
Gentamicin Sulfate	Injection equivalent to 80 mg gentamicin in 2 mL ampoule	Injection	10	1	MX, PU
Eye drops equivalent to 3 mg gentamicin per mL, 5 mL	Application to the eye	1	2	AG
Gestrinone	Capsule 2.5 mg	Oral	8	5	AV
Glatiramer Acetate	Injection 20 mg in 1 mL single dose pre-filled syringe	Injection	28	5	AV
Glibenclamide	Tablet 5 mg	Oral	100	5	AF, AV
Gliclazide	Tablet 30 mg (modified release)	Oral	100	5	SE
Tablet 80 mg	Oral	100	5	AF, AW, CH, GX, HX, SE, TW
Glimepiride	Tablet 1 mg	Oral	30	5	AV, ML
Tablet 2 mg	Oral	30	5	AV, ML
Tablet 3 mg	Oral	30	5	AV, ML
Tablet 4 mg	Oral	30	5	AV, ML
Glipizide	Tablet 5 mg	Oral	100	5	AF, PH
Glucagon Hydrochloride	Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe	Injection	1	1	NO
Glucose	I.V. infusion 278 mmol (anhydrous) per L, 1 L	Injection	5	1	BX
Glucose and Ketone Indicator—Urine	Reagent strips, 50 (Keto-Diabur-Test 5000)	2	2	RD
Reagent strips, 50 (Keto-Diastix)	2	2	BN
Glucose with Sodium Chloride, Potassium Chloride and Sodium Acid Citrate	Oral rehydration salts 3.56 g-470 mg-300 mg-530 mg per sachet, 10	Oral	1	..	AS, AV, CH, TW
Glucose Indicator—Blood	Electrode strips, 50 (Advantage II)	2	5	RD
Electrode strips, 50 (Ascensia Elite)	2	5	BN
Electrode strips, 50 (GlucoCare)	2	5	DR
Electrode strips, 50 (GlucoCare Super Sensor)	2	5	DR
Electrode strips, 50 (GlucoMen Sensor)	2	5	GD
Electrode strips, 50 (Omnitest EZ)	2	5	BR
Electrode strips, 50 (TrueTrack)	2	5	DR
Discs containing electrode sensors, 10 sensors per disc, 5	2	5	BN
Electrode strips, 100 (Optium glucose)	1	5	MS
Electrode strips, 100 (Precision Plus)	1	5	MS
Electrode strips, 100 (SofTact)	1	5	MS
Electrode strips, 100 (TrueSense)	1	5	MS
Reagent strips, 50 (Accu-Chek Active)	2	5	RD
Reagent strips, 50 (Accu-Chek Go)	2	5	RD
Reagent strips, 51 (Accu-Chek Integra)	2	5	RD
Reagent strips, 50 (Betachek)	2	5	NA
Reagent strips, 50 (Betachek MERIDIAN)	2	5	NA
Reagent strips, 50 (CareSens)	2	5	LB
Reagent strips, 50 (Glucoflex-R)	2	5	TC
Reagent strips, 50 (Glucostix)	2	5	BN
Reagent strips, 50 (SensoCard)	2	5	PX
Glucose Indicator—Urine	Reagent strips, 50 (Clinistix)	2	2	BN
Reagent strips, 50 (Diastix)	2	2	BN
Glycerol	Suppositories 700 mg, 12	Rectal	3	5	PP
Suppositories 1.4 g, 12	Rectal	3	5	PP
Suppositories 2.8 g, 12	Rectal	3	5	PP
Glyceryl Trinitrate	Tablets 600 micrograms, 100	Oral	1	5	FM, LM, SI
Buccal/sublingual spray (pump pack) 400 micrograms per dose, 200 doses	Buccal/ sublingual	1	5	AV
Transdermal patch 18 mg	Transdermal	30	5	MM
Transdermal patch 25 mg	Transdermal	30	5	NV
Transdermal patch 40 mg	Transdermal	30	5	SH
Transdermal patch 36 mg	Transdermal	30	5	MM
Transdermal patch 50 mg	Transdermal	30	5	NV
Transdermal patch 80 mg	Transdermal	30	5	SH
Transdermal patch 54 mg	Transdermal	30	5	MM
Transdermal patch 120 mg	Transdermal	30	5	SH
Goserelin Acetate	Subcutaneous implant equivalent to 3.6 mg goserelin in pre-filled injection syringe	Subcutaneous implantation	1	5	AP
Subcutaneous implant (long acting) equivalent to 10.8 mg goserelin in pre-filled injection syringe	Subcutaneous implantation	1	1	AP
Granisetron Hydrochloride	Tablet equivalent to 2 mg granisetron	Oral	2	..	MX
Concentrated injection equivalent to 3 mg granisetron in 3 mL ampoule	Injection	1	..	MX
Griseofulvin	Tablet 125 mg	Oral	100	2	SI
Tablet 500 mg	Oral	28	2	SI
Haloperidol	Tablet 500 micrograms	Oral	100	5	SI
Tablet 1.5 mg	Oral	100	5	SI
Tablet 5 mg	Oral	50	5	SI
Oral solution 2 mg per mL, 100 mL	Oral	1	5	SI
Injection 5 mg in 1 mL ampoule	Injection	10	..	SI
Haloperidol Decanoate	I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule	Injection	5	..	JC
I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule	Injection	5	..	JC
"HCU express"	Sachets containing oral powder 25 g, 30	Oral	4	5	VF
"HCU gel"	Sachets containing oral powder 20 g, 30	Oral	4	5	VF
Heparin Sodium	Injection 5,000 units in 0.2 mL ampoule	Injection	5	5	MX
Injection 5,000 units in 1 mL ampoule	Injection	5	5	MX
Injection (preservative-free) 5,000 I.U. in 5 mL ampoule	Injection	50	5	PU
Injection 35,000 units in 35 mL vial	Injection	12	5	MX
Hexamine Hippurate	Tablet 1 g	Oral	100	5	MM
Homatropine Hydrobromide	Eye drops 20 mg per mL, 15 mL	Application to the eye	1	2	AQ
Eye drops 50 mg per mL, 15 mL	Application to the eye	1	2	AQ
Hydralazine Hydrochloride	Tablet 25 mg	Oral	200	2	AF
Tablet 50 mg	Oral	200	2	AF
Hydrochlorothiazide	Tablet 25 mg	Oral	100	1	PL
Hydrochlorothiazide with Amiloride Hydrochloride	Tablet 50 mg-5 mg	Oral	100	1	AF, MK
Hydrochlorothiazide with Triamterene	Tablet 25 mg-50 mg	Oral	100	1	AF
Hydrocortisone	Tablet 4 mg	Oral	50	4	AF
Tablet 20 mg	Oral	60	4	AF
Eye drops 5 mg per mL, 10 mL	Application to the eye	1	5	SI
Eye drops 10 mg per mL, 10 mL	Application to the eye	1	5	SI
Cream 10 mg per g, 50 g	Application	1	1	EO
Hydrocortisone Acetate	Eye ointment 5 mg per g, 5 g	Application to the eye	1	..	SI
Eye ointment 10 mg per g, 5 g	Application to the eye	1	..	SI
Cream 10 mg per g, 30 g	Application	1	1	FM, SI
Cream 10 mg per g, 50 g	Application	1	1	DT, FM, SI
Ointment 10 mg per g, 30 g	Application	1	1	FM, SI
Ointment 10 mg per g, 50 g	Application	1	1	FM, SI
Rectal foam 90 mg per applicatorful, 14 applications, aerosol 21.1 g	Rectal	2	3	GC
Hydrocortisone Sodium Succinate	Injection equivalent to 100 mg hydrocortisone with 2 mL solvent	Injection	2	..	PH
Injection equivalent to 250 mg hydrocortisone with 2 mL solvent	Injection	1	..	PH
Hydromorphone Hydrochloride	Tablet 2 mg	Oral	20	..	AB
Tablet 4 mg	Oral	20	..	AB
Tablet 8 mg	Oral	20	..	AB
Oral liquid 1 mg per mL, 473 mL	Oral	1	..	AB
Injection 2 mg in 1 mL ampoule	Injection	5	..	AB
Injection 10 mg in 1 mL ampoule	Injection	5	..	AB
Injection 50 mg in 5 mL ampoule	Injection	5	..	AB
Injection 500 mg in 50 mL vial	Injection	1	..	AB
Hydroxocobalamin	Injection 1 mg in 1 mL ampoule	Injection	2	..	MX
Hydroxychloroquine Sulfate	Tablet 200 mg	Oral	100	1	SW
Hydroxypropylcellulose	Ophthalmic inserts 5 mg, 60	Application to the eye	1	5	SI
Hydroxyurea	Capsule 500 mg	Oral	100	..	BQ
Hypromellose	Eye drops 3 mg per mL, 15 mL	Application to the eye	1	5	CV, NV
Eye drops 5 mg per mL, 15 mL	Application to the eye	1	5	AQ, SI
Hypromellose with Carbomer 980	Ocular lubricating gel 3 mg-2 mg per g, 10 g	Application to the eye	1	5	CV, NV
Hypromellose 2900 with Dextran 70	Eye drops 3 mg-1 mg per mL, single dose units 0.4 mL, 28	Application to the eye	3	5	AQ
Hypromellose 4500 with Dextran 70	Eye drops 3 mg-1 mg per mL, 15 mL	Application to the eye	1	5	AQ, IQ
Ibuprofen	Tablet 200 mg	Oral	100	3	AF
Tablet 400 mg	Oral	100	3	AB
Tablets 400 mg, 20	Oral	1	..	AB
Idarubicin Hydrochloride	Capsule 5 mg	Oral	3	..	PH
Capsule 10 mg	Oral	3	..	PH
Solution for I.V. injection 5 mg in 5 mL single use vial	Injection	3	..	PH
Powder for I.V. injection 5 mg in single dose vial	Injection	3	..	PH
Solution for I.V. injection 10 mg in 10 mL single use vial	Injection	6	..	PH
Powder for I.V. injection 10 mg in single dose vial	Injection	6	..	PH
Ifosfamide	Powder for I.V. injection 1 g in single dose vial	Injection	5	5	BX
Powder for I.V. injection 2 g in single dose vial	Injection	5	5	BX
Imipramine Hydrochloride	Tablet 10 mg	Oral	50	2	NV
Tablet 25 mg	Oral	50	2	NV, UW
Indapamide Hemihydrate	Tablet 1.5 mg (sustained release)	Oral	90	1	SE
Tablet 2.5 mg	Oral	90	1	AF, CH, DP, GX, HX, SE, SI, TW
Indomethacin	Capsule 25 mg	Oral	100	3	AF, MK
Suppository 100 mg	Rectal	40	3	MK
Influenza Vaccine (Split Virion) - Inactivated	Injection containing antigens representative of the following types: A/New Caledonia/20/99 (H1N1)-like strain 15 micrograms haemagglutinin; A/Wellington/1/2004 (H3N2)-like strain 15 micrograms haemagglutinin; B/Shanghai/361/2002-like strain 15 micrograms haemagglutinin; 0.5 mL pre-filled syringe	Injection	1	..	AX, CS, GK, SM
Insect Allergen Extract—Honey Bee Venom	Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL	Injection	1	..	TH
Insect Allergen Extract—Paper Wasp Venom	Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL	Injection	1	..	TH
Insect Allergen Extract—Yellow Jacket Venom	Injection set containing 550 micrograms vial with 9 mL vial solvent and 3 vials diluent 1.8 mL	Injection	1	..	TH
Insulin - Isophane	Injection (bovine) 100 units per mL, 10 mL vial	Injection	5	2	AS
Injection (human) 100 units per mL, 10 mL vial	Injection	5	2	LY, NO
Injections (human), cartridges, 100 units per mL, 3 mL, 5	Injection	5	1	LY, NI, NL, NO
Insulin - Neutral	Injection (bovine) 100 units per mL, 10 mL vial	Injection	5	2	AS
Injection (human) 100 units per mL, 10 mL vial	Injection	5	2	LY, NO
Injections (human), cartridges, 100 units per mL, 3 mL, 5	Injection	5	1	LY, NO
Insulin - Neutral with Insulin - Isophane	Injection (human) 30 units-70 units per mL, 10 mL vial	Injection	5	2	LY, NO
Injection (human) 50 units-50 units per mL, 10 mL vial	Injection	5	2	NO
Injections (human), cartridges, 20 units-80 units per mL, 3 mL, 5	Injection	5	1	NO
Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5	Injection	5	1	LY, NI, NO
Injections (human), cartridges, 50 units-50 units per mL, 3 mL, 5	Injection	5	1	NO
Insulin Aspart	Injection (human analogue) 100 units per mL, 10 mL vial	Injection	5	2	NO
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5	Injection	5	1	NF, NO
Insulin Aspart with Insulin Aspart Protamine Suspension	Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5	Injection	5	1	NF, NO
Insulin Lispro	Injection (human analogue) 100 units per mL, 10 mL vial	Injection	5	2	LY
Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5	Injection	5	1	LY
Insulin Lispro with Insulin Lispro Protamine Suspension	Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5	Injection	5	1	LY
Interferon Alfa-2a	Injection 3,000,000 I.U. in 0.5 mL single dose pre-filled syringe	Injection	15	4	RO
Injection 4,500,000 I.U. in 0.5 mL single dose pre-filled syringe	Injection	5	4	RO
Injection 6,000,000 I.U. in 0.5 mL single dose pre-filled syringe	Injection	5	4	RO
Injection 9,000,000 I.U. in 0.5 mL single dose pre-filled syringe	Injection	5	4	RO
Interferon Alfa-2b	Solution for injection 18,000,000 I.U. in 1.2 mL multi-dose injection pen	Injection	3	4	SH
Solution for injection 30,000,000 I.U. in 1.2 mL multi-dose injection pen	Injection	3	5	SH
Interferon Beta-1a	Injection set comprising 1 vial powder for injection 30 micrograms (6,000,000 I.U.) with diluent	Injection	4	5	BD
Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre-filled syringe	Injection	4	5	BD
Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre-filled syringe	Injection	12	5	SG
Interferon Beta-1b	Injection set comprising 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent	Injection	15	5	SC
Ipratropium Bromide	Pressurised inhalation 21 micrograms per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	2	5	BY
Nebuliser solution 250 micrograms (anhydrous) in 1 mL single dose units, 30	Inhalation	2	5	AF, AW, BY, CH, DP, GX, MX, PU, TW
Nebuliser solution 500 micrograms (anhydrous) in 1 mL single dose units, 30	Inhalation	2	5	AF, AW, BY, CH, DP, GX, MX, PU, TW
Nebuliser solution 250 micrograms (anhydrous) per mL, 20 mL	Inhalation	2	2	BY
Irbesartan	Tablet 75 mg	Oral	30	5	BQ, SW
Tablet 150 mg	Oral	30	5	BQ, SW
Tablet 300 mg	Oral	30	5	BQ, SW
Irbesartan with Hydrochlorothiazide	Tablet 150 mg-12.5 mg	Oral	30	5	BQ, SW
Irbesartan with Hydrochlorothiazide	Tablet 300 mg-12.5 mg	Oral	30	5	BQ, SW
Irinotecan Hydrochloride Trihydrate	I.V. injection 40 mg in 2 mL vial	Injection	1	3	MX, PU
Irinotecan Hydrochloride Trihydrate	I.V. injection 100 mg in 5 mL vial	Injection	2	3	MX, PU
Iron Polymaltose Complex	Injection 100 mg (iron) in 2 mL ampoule	Injection	5	..	BX, SI
Iron Sucrose	Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL ampoule	Injection	5	..	BX
Isoniazid	Tablet 100 mg	Oral	100	2	FM
Isosorbide Dinitrate	Tablet 10 mg	Oral	200	2	AF, SI
Tablet 5 mg (sublingual)	Oral	200	2	SI
Isosorbide Mononitrate	Tablet 60 mg (sustained release)	Oral	30	5	AF, AP, AW, CH, DP, GX, HX, PM, TW
Tablet 120 mg (sustained release)	Oral	30	5	AP, PM
Isotretinoin	Capsule 10 mg	Oral	60	3	DP, GX, HX, RO
Capsule 20 mg	Oral	60	3	CH, DP, GX, HX, RO, TW
Itraconazole	Capsule 100 mg	Oral	60	5	JC
Ivermectin	Tablet 3 mg	Oral	4	..	MK
"Karicare De-Lact"	Oral powder 900 g	Oral	5	..	NU
Ketoconazole	Tablet 200 mg	Oral	10	..	JC
"Ketonex-1"	Oral powder 350 g	Oral	8	5	AB
Oral powder 400 g	Oral	8	5	AB
"Ketonex-2"	Oral powder 325 g	Oral	10	5	AB
Oral powder 400 g	Oral	8	5	AB
Ketoprofen	Capsule 200 mg (sustained release)	Oral	28	3	AV, HP
Suppository 100 mg	Rectal	40	3	AV
"Kindergen"	Oral powder 400 g	Oral	16	5	SB
Labetalol Hydrochloride	Tablet 100 mg	Oral	100	5	AF, SI
Tablet 200 mg	Oral	100	5	AF, SI
Lactulose	Solution BP 3.34 g per 5 mL, 500 mL	Oral	1	5	AF, AW, DP, GX, HX, SM
Lamotrigine	Tablet 5 mg	Oral	56	5	AF, AW, GK, HX, ME
Tablet 25 mg	Oral	56	5	AF, AW, DP, GK, GX, HX, ME
Tablet 50 mg	Oral	56	5	AF, AW, DP, GK, GX, HX, ME
Tablet 100 mg	Oral	56	5	AF, AW, DP, GK, GX, HX, ME
Tablet 200 mg	Oral	56	5	AF, AW, DP, GK, GX, HX, ME
Lansoprazole	Capsule 30 mg	Oral	30	1	WY
Sachet containing granules for oral suspension, 30 mg per sachet	Oral	28	1	WY
Capsule 15 mg	Oral	30	5	WY
Latanoprost	Eye drops 50 micrograms per mL, 2.5 mL	Application to the eye	1	5	PU
Leflunomide	Pack containing 3 tablets leflunomide 100 mg and 30 tablets leflunomide 20 mg	Oral	1	..	AV
Tablet 10 mg	Oral	30	5	AV, HP
Tablet 20 mg	Oral	30	5	AV, HP
Lercanidipine Hydrochloride	Tablet 10 mg	Oral	30	5	SM
Tablet 20 mg	Oral	30	5	SM
Letrozole	Tablet 2.5 mg	Oral	30	2	NV
Leuprorelin Acetate	I.M. injection (modified release), set containing 1 vial powder for injection 7.5 mg, 1 ampoule diluent 2 mL and 1 syringe with 2 needles	Injection	1	5	AB
Suspension for subcutaneous injection (modified release), 7.5 mg injection set	Injection	1	5	MX
I.M. injection (modified release), set containing 1 vial powder for injection 22.5 mg, 1 ampoule diluent 2 mL and 1 syringe with 2 needles	Injection	1	1	AB
Suspension for subcutaneous injection (modified release), 22.5 mg injection set	Injection	1	1	MX
I.M. injection (modified release), set containing 1 vial powder for injection 30 mg, 1 ampoule diluent 2 mL and 1 syringe with 2 needles	Injection	1	1	AB
Suspension for subcutaneous injection (modified release), 30 mg injection set	Injection	1	1	MX
Suspension for subcutaneous injection (modified release), 45 mg injection set	Injection	1	..	MX
Levetiracetam	Tablet 250 mg	Oral	60	5	UC
Tablet 500 mg	Oral	60	5	UC
Tablet 1 g	Oral	60	5	UC
Levobunolol Hydrochloride	Eye drops 2.5 mg per mL, 5 mL	Application to the eye	1	5	AG
Levodopa with Benserazide Hydrochloride	Dispersible tablet 50 mg-12.5 mg (benserazide)	Oral	100	5	RO
Dispersible tablet 100 mg-25 mg (benserazide)	Oral	100	5	RO
Tablet 100 mg-25 mg (benserazide)	Oral	100	5	RO
Tablet 200 mg-50 mg (benserazide)	Oral	100	5	RO
Capsule 50 mg-12.5 mg (benserazide)	Oral	100	5	RO
Capsule 100 mg-25 mg (benserazide)	Oral	100	5	RO
Capsule 100 mg-25 mg (benserazide) (sustained release)	Oral	100	5	RO
Capsule 200 mg-50 mg (benserazide)	Oral	100	5	RO
Levodopa with Carbidopa	Tablet 200 mg-50 mg (anhydrous) (modified release)	Oral	100	5	MK
Tablet 100 mg-25 mg (anhydrous)	Oral	100	5	AF, MK
Tablet 250 mg-25 mg (anhydrous)	Oral	100	5	HX, MK
Levodopa with Carbidopa and Entacapone	Tablet 50 mg-12.5 mg-200 mg	Oral	200	4	NV
Levodopa with Carbidopa and Entacapone	Tablet 100 mg-25 mg-200 mg	Oral	200	4	NV
Tablet 150 mg-37.5 mg-200 mg	Oral	200	4	NV
Levonorgestrel	Tablets 30 micrograms, 28	Oral	4	2	SC, WY
Intrauterine drug delivery system 52 mg	Intrauterine	1	..	SC
Levonorgestrel with Ethinyloestradiol	Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets	Oral	4	2	SC
Tablets 150 micrograms-30 micrograms, 21	Oral	4	2	SC
Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets	Oral	4	2	SC, SY, WX, WY
Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets	Oral	4	2	SC, SY, WX, WY
Lignocaine Hydrochloride	Injection 100 mg in 5 mL	Injection	5	..	PF
Infusion 500 mg in 5 mL ampoule	Injection	10	..	AP
Lincomycin Hydrochloride	Injection equivalent to 600 mg lincomycin in 2 mL vial	Injection	5	..	PH
Liothyronine Sodium	Tablet 20 micrograms	Oral	100	2	SI
Lisinopril	Tablet 5 mg	Oral	30	5	AF, AP, AW, BF, CH, DP, GX, HX, MK, TW
Tablet 10 mg	Oral	30	5	AF, AP, AW, BF, CH, DP, GX, HX, MK, TW
Tablet 20 mg	Oral	30	5	AF, AP, AW, BF, CH, DP, GX, HX, MK, TW
Lithium Carbonate	Tablet 250 mg	Oral	200	2	AS
Tablet 450 mg (slow release)	Oral	200	2	GK
"Locasol"	Low calcium compound powder 400 g	Oral	8	5	NU
Lodoxamide Trometamol	Eye drops equivalent to 1 mg lodoxamide per mL, 10 mL	Application to the eye	1	5	AQ
Loperamide Hydrochloride	Capsule 2 mg	Oral	12	..	AS, JC
"Lophlex"	Sachets containing oral powder 27.8 g, 30	Oral	3	5	SB
Macrogol 3350 with Sodium Chloride, Sodium Bicarbonate and Potassium Chloride	Sachets containing powder for oral solution 13.125 g-350.7 mg-178.5 mg-46.6 mg, 30	Oral	1	5	NE
"Mapleflex"	Sachets containing oral powder 29 g, 30	Oral	4	5	SB
Medroxyprogesterone Acetate	Tablet 500 mg	Oral	30	2	PH
Tablet 100 mg	Oral	100	2	PH
Tablet 200 mg	Oral	60	2	PH
Tablet 250 mg	Oral	60	2	PH
Tablet 5 mg	Oral	56	2	KR, PH
Tablet 10 mg	Oral	30	2	HX, KR, PH
Injection 50 mg in 1 mL vial	Injection	1	1	PH
Injection 150 mg in 1 mL vial	Injection	1	1	KR, PH
Mefenamic Acid	Capsule 250 mg	Oral	50	2	PC, PD
Megestrol Acetate	Tablet 160 mg	Oral	30	2	BQ
Meloxicam	Tablet 7.5 mg	Oral	30	3	AW, BY
Tablet 15 mg	Oral	30	3	AW, BY
Melphalan	Tablet 2 mg	Oral	25	1	GK
Mercaptopurine	Tablet 50 mg	Oral	100	2	GK
Mesalazine	Tablet 250 mg	Oral	100	5	GK
Tablet 500 mg (enteric coated)	Oral	100	5	OA
Sachet containing granules, 500 mg per sachet	Oral	100	5	OA
Sachet containing granules, 1 g per sachet	Oral	100	2	OA
Suppositories 1 g, 28	Rectal	1	..	FP
Enemas 2 g in 60 mL, 7	Rectal	4	..	OA
Enemas 4 g in 60 mL, 7	Rectal	4	..	OA
Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g	Rectal	4	..	OA
Enemas 1 g in 100 mL, 7	Rectal	4	..	FP
Mesna	Solution for I.V. injection 400 mg in 4 mL ampoule	Injection	15	5	BX
Solution for I.V. injection 1 g in 10 mL ampoule	Injection	15	5	BX
"Metabolic Mineral Mixture"	Oral powder 250 g	Oral	1	5	SB
Metformin Hydrochloride	Tablet 500 mg	Oral	100	5	AF, AL, AW, CH, DP, GX, HX, MQ, TW
Tablet 850 mg	Oral	60	5	AF, AL, AW, CH, DP, GX, HX, MQ, TW
Tablet 1 g	Oral	90	5	AF, AL, AW
Metformin Hydrochloride with Glibenclamide	Tablet 250 mg-1.25 mg Tablet 500 mg-2.5 mg	Oral Oral	90 90	5 5	AL AL
Tablet 500 mg-5 mg	Oral	90	5	AL
Methadone Hydrochloride	Tablet 10 mg	Oral	20	..	GK
Injection 10 mg in 1 mL ampoule	Injection	5	..	GK
Methotrexate	Tablet 2.5 mg	Oral	30	5	MX, PH, WY
Tablet 10 mg	Oral	50	2	PH
Injection 5 mg in 2 mL vial	Injection	5	..	MX
Injection 50 mg in 2 mL vial	Injection	5	..	MX, PU
Solution concentrate for I.V. infusion 500 mg in 5 mL vial	Injection	1	..	IT
Solution concentrate for I.V. infusion 500 mg in 20 mL vial	Injection	1	..	MX
Solution concentrate for I.V. infusion 1000 mg in 10 mL vial	Injection	1	..	IT, MX
Solution concentrate for I.V. infusion 5000 mg in 50 mL vial	Injection	1	..	IT
Methyldopa	Tablet 250 mg	Oral	100	5	AF, MK
Methylphenidate Hydrochloride	Tablet 10 mg	Oral	100	5	AF, NV
Methylprednisolone Aceponate	Cream 1 mg per g, 15 g	Application	1	..	SC
Ointment 1 mg per g, 15 g	Application	1	..	SC
Fatty ointment 1 mg per g, 15 g	Application	1	..	SC
Lotion 1 mg per g, 20 g	Application	1	..	SC
Methylprednisolone Acetate	Injection 40 mg in 1 mL vial	Injection	5	..	KR, PH
Methylprednisolone Sodium Succinate	Powder for injection equivalent to 40 mg methylprednisolone with diluent	Injection	5	..	PF
Powder for injection equivalent to 1 g methylprednisolone with diluent	Injection	1	..	PF
Methysergide Maleate	Tablet equivalent to 1 mg methysergide	Oral	100	2	NV
Metoclopramide Hydrochloride	Tablet 10 mg	Oral	25	..	AF, VT
Oral solution 5 mg per 5 mL, 100 mL	Oral	1	..	VT
Injection 10 mg in 2 mL ampoule	Injection	10	..	VT
Metoprolol Succinate	Pack containing 15 tablets 23.75 mg (controlled release), 15 tablets 47.5 mg (controlled release) and 15 tablets 95 mg (controlled release)	Oral	1	..	AP
Tablet 23.75 mg (controlled release)	Oral	15	..	AP
Tablet 47.5 mg (controlled release)	Oral	30	5	AP
Tablet 95 mg (controlled release)	Oral	30	5	AP
Tablet 190 mg (controlled release)	Oral	30	5	AP
Metoprolol Tartrate	Tablet 50 mg	Oral	100	5	AF, AP, AW, CH, DP, GX, HX, NV, TW
Tablet 100 mg	Oral	60	5	AF, AP, AW, CH, DP, GX, HX, NV, TW
Metronidazole	Tablet 200 mg	Oral	21	1	AF, AV, HP
Tablet 400 mg	Oral	5	2	AF
I.V. infusion 500 mg in 100 mL	Injection	5	1	BX
Suppositories 500 mg, 10	Rectal	1	..	AV
Metronidazole Benzoate	Oral suspension 320 mg per 5 mL, 100 mL	Oral	1	..	AV
Mexiletine Hydrochloride	Capsule 50 mg	Oral	100	5	BY
Capsule 200 mg	Oral	100	5	BY
Mianserin Hydrochloride	Tablet 10 mg	Oral	50	5	AF, OR
Tablet 20 mg	Oral	50	5	AF, OR
"Minaphlex"	Sachets containing oral powder 29 g, 30	Oral	4	5	SB
Minocycline Hydrochloride	Tablet equivalent to 50 mg minocycline	Oral	60	5	AF, SI
Capsule equivalent to 100 mg minocycline	Oral	11	..	AF
Minoxidil	Tablet 10 mg	Oral	100	5	PH
Mirtazapine	Tablet 15 mg (orally disintegrating)	Oral	30	5	BP
Tablet 30 mg	Oral	30	5	AF, AW, BP, OR
Tablet 30 mg (orally disintegrating)	Oral	30	5	BP
Tablet 45 mg (orally disintegrating)	Oral	30	5	BP
Misoprostol	Tablet 200 micrograms	Oral	120	2	PH
Mitozantrone Hydrochloride	Injection equivalent to 10 mg mitozantrone in 5 mL vial	Injection	1	..	PU
Injection equivalent to 20 mg mitozantrone in 10 mL vial	Injection	1	..	BX, PU, SI
Injection equivalent to 25 mg mitozantrone in 12.5 mL vial	Injection	1	..	BX, PU, SI
Moclobemide	Tablet 150 mg	Oral	60	5	AF, CH, DP, GX, HX, RO, TW
Tablet 300 mg	Oral	60	5	AF, CH, DP, GX, HX, RO, SI, TW
Modafinil	Tablet 100 mg	Oral	120	5	CS
Mometasone Furoate	Cream 1 mg per g, 15 g	Application	1	..	EX, SH
Ointment 1 mg per g, 15 g	Application	1	..	EX, SH
Lotion 1 mg per g, 30 mL	Application	1	..	EX, SH
"Monogen"	Oral powder 400 g	Oral	8	5	SB
Montelukast Sodium	Tablet, chewable, equivalent to 4 mg montelukast	Oral	28	5	MK
Tablet, chewable, equivalent to 5 mg montelukast	Oral	28	5	MK
Morphine Hydrochloride	Oral solution 2 mg per mL, 200 mL	Oral	1	..	MF
Oral solution 5 mg per mL, 200 mL	Oral	1	..	MF
Oral solution 10 mg per mL, 200 mL	Oral	1	..	MF
Morphine Sulfate	Tablet 10 mg	Oral	20	..	MF
Tablet 20 mg	Oral	20	..	MF
Tablet 30 mg	Oral	20	..	FM
Tablet 5 mg (controlled release)	Oral	20	..	MF
Tablet 10 mg (controlled release)	Oral	20	..	MF
Tablet 15 mg (controlled release)	Oral	20	..	MF
Tablet 30 mg (controlled release)	Oral	20	..	MF
Tablet 60 mg (controlled release)	Oral	20	..	MF
Tablet 100 mg (controlled release)	Oral	20	..	MF
Tablet 200 mg (controlled release)	Oral	20	..	MF
Capsule 10 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 20 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 30 mg (controlled release)	Oral	10	..	MF
Capsule 50 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 60 mg (controlled release)	Oral	10	..	MF
Capsule 90 mg (controlled release)	Oral	10	..	MF
Capsule 100 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 120 mg (controlled release)	Oral	10	..	MF
Sachet containing controlled release granules for oral suspension, 20 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 30 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 60 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 100 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 200 mg per sachet	Oral	20	..	MF
Injection 10 mg in 1 mL ampoule	Injection	5	..	MX, SI
Injection 15 mg in 1 mL ampoule	Injection	5	..	MX, SI
Injection 30 mg in 1 mL ampoule	Injection	5	..	MX
Morphine Tartrate	Injection 120 mg in 1.5 mL ampoule	Injection	5	..	MX
Moxifloxacin Hydrochloride	Solution for I.V. infusion equivalent to 400 mg moxifloxacin in 250 mL	Injection	3	..	BN
Tablet equivalent to 400 mg moxifloxacin	Oral	5	1	BN
"MSUD AID III"	Oral powder 500 g	Oral	4	5	SB
"MSUD Analog"	Oral powder 400 g	Oral	8	5	SB
"MSUD Express"	Sachets containing oral powder 25 g, 30	Oral	4	5	VF
"MSUD Maxamaid"	Oral powder 500 g	Oral	8	5	SB
"MSUD Maxamum"	Oral powder 500 g	Oral	8	5	SB
"MSUD-gel"	Sachets containing oral powder 20 g, 30	Oral	4	5	VF
Mycophenolate Mofetil	Capsule 250 mg	Oral	300	3	RO
Tablet 500 mg	Oral	150	3	RO
Mycophenolate Mofetil with Water - Purified BP	Powder for oral suspension 1 g per 5 mL, 165 mL	Oral	1	3	RO
Mycophenolate Sodium	Tablet (enteric coated) equivalent to 180 mg mycophenolic acid	Oral	120	3	NV
Tablet (enteric coated) equivalent to 360 mg mycophenolic acid	Oral	120	3	NV
Nafarelin Acetate	Nasal spray (pump pack) equivalent to 200 micrograms nafarelin per dose, 60 doses	Nasal	1	5	PH
Naloxone Hydrochloride	Injection 400 micrograms in 1 mL disposable injection set	Injection	1	..	CS
Injection 800 micrograms in 2 mL disposable injection set	Injection	1	..	CS
Injection 2 mg in 5 mL disposable injection set	Injection	1	..	CS
Naltrexone Hydrochloride	Tablet 50 mg	Oral	30	1	BQ
Nandrolone Decanoate	Injection 50 mg in 1 mL disposable syringe	Injection	1	7	OR
Naproxen	Tablet 250 mg	Oral	100	3	AF, RO
Tablet 500 mg	Oral	50	3	AF, RO
Tablet 750 mg (sustained release)	Oral	28	3	MD, RO
Tablet 1 g (sustained release)	Oral	28	3	MD, RO
Naproxen Sodium	Tablet 550 mg	Oral	50	3	MD, RO
Naratriptan Hydrochloride	Tablet equivalent to 2.5 mg naratriptan	Oral	4	5	GK
Nedocromil Sodium	Pressurised inhalation 2 mg per dose, 112 doses (CFC-free formulation)	Inhalation by mouth	1	5	AV
"Neocate"	Oral powder 400 g	Oral	8	5	SB
"Neocate Advance"	Oral powder 400 g	Oral	8	5	SB
Neomycin Sulfate	Tablet 500 mg	Oral	25	1	AF
Neomycin Undecenoate with Bacitracin Zinc	Ear ointment 12 mg (3.5 mg neomycin)-400 units per g, 10 g	Application to the ear	1	..	HA
Nicorandil	Tablets 10 mg, 60	Oral	1	5	AV
Tablets 20 mg, 60	Oral	1	5	AV
Nifedipine	Tablet 10 mg	Oral	60	5	AF, AW, BN
Tablet 20 mg	Oral	60	5	AF, AW, BN, CH, DP, GX, HX, TW
Tablet 20 mg (controlled release)	Oral	30	5	BN
Tablet 30 mg (controlled release)	Oral	30	5	AF, AW, BN
Tablet 60 mg (controlled release)	Oral	30	5	AF, AW, BN
Nilutamide	Tablet 150 mg	Oral	30	5	AV
Nitrazepam	Tablet 5 mg	Oral	25	..	AF, VT
Nitrofurantoin	Capsule 50 mg	Oral	30	1	PU
Capsule 100 mg	Oral	30	1	PU
Nizatidine	Capsule 150 mg	Oral	60	5	AS, LN
Capsule 300 mg	Oral	30	5	AS, LN
Norethisterone	Tablets 350 micrograms, 28	Oral	4	2	JC, KR, PH
Tablet 5 mg	Oral	30	2	SC
Norethisterone with Ethinyloestradiol	Tablets 500 micrograms-35 micrograms, 21	Oral	4	2	PH
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets	Oral	4	2	KR, PH
Tablets 1 mg-35 micrograms, 21	Oral	4	2	PH
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets	Oral	4	2	KR, PH
Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets	Oral	4	2	KR, PH
Norethisterone with Mestranol	Tablets 1 mg-50 micrograms, 21	Oral	4	2	PH
Pack containing 21 tablets 1 mg-50 micrograms and 7 inert tablets	Oral	4	2	PH
Norfloxacin	Tablet 400 mg	Oral	14	1	AF, AW, CH, DP, FR, GX, HX, MK, TW
Nortriptyline Hydrochloride	Tablet equivalent to 10 mg nortriptyline	Oral	50	2	AS
Tablet equivalent to 25 mg nortriptyline	Oral	50	2	AS
Nystatin	Tablet 500,000 units	Oral	50	..	SI
Capsule 500,000 units	Oral	50	..	SI
Oral suspension 100,000 units per mL, 24 mL	Oral	1	1	BQ, SI
Oestradiol	Tablet 2 mg	Oral	56	2	SM
Transdermal patches 390 micrograms, 8	Transdermal	1	5	NV
Transdermal patches 2 mg, 4	Transdermal	1	5	MM, SC
Transdermal patches 2 mg, 8 (Dermestril 25)	Transdermal	1	5	MX
Transdermal patches 2 mg, 8 (Estraderm 25)	Transdermal	1	5	NV
Transdermal patches 585 micrograms, 8	Transdermal	1	5	NV
Transdermal patches 3.28 mg, 8	Transdermal	1	5	NV
Transdermal patches 780 micrograms, 8	Transdermal	1	5	NV
Transdermal patches 3.8 mg, 4	Transdermal	1	5	MM, SC
Transdermal patches 4 mg, 8 (Dermestril 50)	Transdermal	1	5	MX
Transdermal patches 4 mg, 8 (Estraderm 50)	Transdermal	1	5	NV
Transdermal patches 4.33 mg, 8	Transdermal	1	5

Transdermal patches 1.17 mg, 8	Transdermal	1	5	NV
Transdermal patches 5.7 mg, 4	Transdermal	1	5	SC
Transdermal patches 6.57 mg, 8	Transdermal	1	5	NV
Transdermal patches 1.56 mg, 8	Transdermal	1	5	NV
Transdermal patches 7.6 mg, 4	Transdermal	1	5	MM, SC
Transdermal patches 8 mg, 8 (Dermestril 100)	Transdermal	1	5	MX
Transdermal patches 8 mg, 8 (Estraderm 100)	Transdermal	1	5	NV
Transdermal patches 8.66 mg, 8	Transdermal	1	5	NV
Vaginal tablets 25 micrograms, 15	Vaginal	1	2	NO
Oestradiol and Oestradiol with Dydrogesterone	Pack containing 14 tablets oestradiol 2 mg and 14 tablets oestradiol 2 mg with dydrogesterone 10 mg	Oral	1	5	SM
Oestradiol and Oestradiol with Norethisterone Acetate	Pack containing 12 tablets oestradiol 2 mg, 10 tablets oestradiol 2 mg with norethisterone acetate 1 mg and 6 tablets oestradiol 1 mg	Oral	1	5	NO
Pack containing 4 transdermal patches oestradiol 4 mg and 4 transdermal patches oestradiol 10 mg with norethisterone acetate 30 mg	Transdermal	1	5	NV
Oestradiol Hemihydrate	Nasal spray 150 micrograms per actuation, 60 actuations, 4.2 mL	Nasal	1	5	SE
Transdermal gel equivalent to 1 mg oestradiol in 1 g sachet, 28	Transdermal	1	5	OR
Transdermal patches equivalent to 750 micrograms oestradiol, 8	Transdermal	1	5	NV
Transdermal patches equivalent to 1.5 mg oestradiol, 8	Transdermal	1	5	NV
Transdermal patches equivalent to 3 mg oestradiol, 8	Transdermal	1	5	NV
Oestradiol Hemihydrate and Oestradiol Hemihydrate with Norethisterone Acetate	Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate	Transdermal	1	5	NV
Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate	Transdermal	1	5	NV
Oestradiol Hemihydrate with Norethisterone Acetate	Tablets equivalent to 1 mg oestradiol with 500 micrograms norethisterone acetate, 28	Oral	1	5	NO
Tablets equivalent to 2 mg oestradiol with 1 mg norethisterone acetate, 28	Oral	1	5	NO
Transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate, 8	Transdermal	1	5	NV
Transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate, 8	Transdermal	1	5	NV
Oestradiol Valerate	Tablet 1 mg	Oral	56	2	SC
Tablet 2 mg	Oral	56	2	SC
Injection 10 mg in 1 mL ampoule	Injection	3	..	SC
Oestradiol Valerate and Oestradiol Valerate with Cyproterone Acetate	Pack containing 11 tablets oestradiol valerate 2 mg and 10 tablets oestradiol valerate 2 mg with cyproterone acetate 1 mg	Oral	1	5	SC
Oestriol	Tablet 1 mg	Oral	60	2	OR
Pessaries 500 micrograms, 15	Vaginal	1	2	OR
Vaginal cream 1 mg per g, 15 g	Application	1	1	OR
Oestrogens—Conjugated	Tablet 300 micrograms	Oral	56	2	WY
Tablet 625 micrograms	Oral	56	2	WY
Oestrogens—Conjugated with Medroxyprogesterone Acetate	Tablets 625 micrograms-2.5 mg, 28	Oral	1	5	WY
Tablets 625 micrograms-5 mg, 28	Oral	1	5	WY
Ofloxacin	Eye drops 3 mg per mL, 5 mL	Application to the eye	2	..	AG
Olanzapine	Tablet 2.5 mg	Oral	30	5	LY
Tablet 5 mg	Oral	30	5	LY
Tablet 7.5 mg	Oral	30	5	LY
Tablet 10 mg	Oral	30	5	LY
Wafer 5 mg	Oral	28	5	LY
Wafer 10 mg	Oral	28	5	LY
Olsalazine Sodium	Capsule 250 mg	Oral	100	5	UC
Tablet 500 mg	Oral	100	5	UC
Omeprazole	Tablet 20 mg	Oral	30	1	HX
Capsule 20 mg	Oral	30	1	SZ
Omeprazole and Clarithromycin and Amoxycillin Trihydrate	Pack containing 14 capsules omeprazole 20 mg, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin	Oral	1	..	AB
Omeprazole Magnesium	Tablet equivalent to 20 mg omeprazole	Oral	30	1	AL, AP
Tablet equivalent to 10 mg omeprazole	Oral	30	5	AP
Ondansetron	Wafer 4 mg	Oral	4	..	GK
Wafer 8 mg	Oral	4	..	GK
Ondansetron Hydrochloride Dihydrate	Tablet equivalent to 4 mg ondansetron	Oral	4	..	GK
Tablet equivalent to 8 mg ondansetron	Oral	4	..	GK
Syrup equivalent to 4 mg ondansetron per 5 mL, 50 mL	Oral	1	1	GK
I.V. injection equivalent to 4 mg ondansetron in 2 mL ampoule	Injection	1	..	GK
I.V. injection equivalent to 8 mg ondansetron in 4 mL ampoule	Injection	1	..	GK
Oxaliplatin	Powder for I.V. infusion 50 mg, vial	Injection	1	2	SW
Solution concentrate for I.V. infusion 50 mg in 10 mL vial	Injection	1	2	SW
Powder for I.V. infusion 100 mg, vial	Injection	1	2	SW
Solution concentrate for I.V. infusion 100 mg in 20 mL vial	Injection	1	2	SW
Oxandrolone	Tablet 2.5 mg	Oral	100	1	CS
Oxazepam	Tablet 15 mg	Oral	25	..	AF, SI
Tablet 30 mg	Oral	25	..	AF, FM, SI
Oxcarbazepine	Tablet 150 mg	Oral	100	5	NV
Tablet 300 mg	Oral	100	5	NV
Tablet 600 mg	Oral	100	5	NV
Oral suspension 60 mg per mL, 250 mL	Oral	2	5	NV
Oxprenolol Hydrochloride	Tablet 20 mg	Oral	100	5	AF
Tablet 40 mg	Oral	100	5	AF
Oxybutynin Hydrochloride	Tablet 5 mg	Oral	100	5	AV
Oxycodone Hydrochloride	Tablet 5 mg	Oral	20	..	SI
Capsule 5 mg	Oral	20	..	MF
Capsule 10 mg	Oral	20	..	MF
Capsule 20 mg	Oral	20	..	MF
Oral solution 5 mg per 5 mL, 250 mL	Oral	1	..	MF
Tablet 5 mg (controlled release)	Oral	20	..	MF
Tablet 10 mg (controlled release)	Oral	20	..	MF
Tablet 20 mg (controlled release)	Oral	20	..	MF
Tablet 40 mg (controlled release)	Oral	20	..	MF
Tablet 80 mg (controlled release)	Oral	20	..	MF
Oxycodone Pectinate	Suppository equivalent to 30 mg oxycodone	Rectal	12	..	PL
Paclitaxel	Solution concentrate for I.V. infusion 30 mg in 5 mL vial	Injection	5	..	BQ, IT, MX
Solution concentrate for I.V. infusion 100 mg in 16.7 mL vial	Injection	2	..	BQ, IT, MX
Solution concentrate for I.V. infusion 150 mg in 25 mL vial	Injection	2	..	IT, MX
Solution concentrate for I.V. infusion 300 mg in 50 mL vial	Injection	1	..	BQ, IT, MX
Pancreatic Extract	Capsule (containing enteric coated minimicrospheres) providing not less than 5,000 BP units of lipase activity	Oral	500	10	SM
Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity	Oral	500	10	SM
Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity	Oral	200	10	SM
Pancrelipase	Capsule (containing enteric coated microspheres) providing not less than 10,000 BP units of lipase activity	Oral	500	10	OR
Capsule (containing enteric coated microtablets) providing not less than 25,000 BP units of lipase activity	Oral	200	10	TM
Pantoprazole Sodium Sesquihydrate	Tablet (enteric coated), equivalent to 40 mg pantoprazole	Oral	30	2	PH
Tablet (enteric coated), equivalent to 20 mg pantoprazole	Oral	30	5	PH
Paracetamol	Tablet 500 mg	Oral	100	1	AW, DG, FM, HX, JT, PC, SW, TW
Tablet 665 mg (modified release)	Oral	192	5	GC, ME
Oral liquid 120 mg per 5 mL, 100 mL	Oral	1	2	SW
Oral liquid 240 mg per 5 mL, 200 mL	Oral	1	2	SW
Paraffin - Soft White with Paraffin - Liquid	Eye ointment, compound, 3.5 g	Application to the eye	2	5	AQ, IQ
Pack containing 2 tubes eye ointment, compound, 3.5 g	Application to the eye	1	5	AG, IQ, PE
Paroxetine Hydrochloride	Tablet equivalent to 20 mg paroxetine	Oral	30	5	AF, CH, GK, GX, HX, TW
Pemetrexed Disodium Heptahydrate	Powder for I.V. infusion equivalent to 500 mg pemetrexed, vial	Injection	2	2	LY
Penicillamine	Tablet 125 mg	Oral	100	1	AL
Tablet 250 mg	Oral	100	1	AL
"Pepti-Junior"	Oral powder 450 g	Oral	8	5	NU
Pergolide Mesylate	Tablet equivalent to 50 micrograms pergolide	Oral	100	..	AS
Tablet equivalent to 250 micrograms pergolide	Oral	100	5	AS
Tablet equivalent to 1 mg pergolide	Oral	100	5	AS
Perhexiline Maleate	Tablet 100 mg	Oral	100	5	SI
Pericyazine	Tablet 2.5 mg	Oral	100	5	AV
Tablet 10 mg	Oral	100	5	AV
Perindopril Erbumine	Tablet 2 mg	Oral	30	5	SE
Tablet 4 mg	Oral	30	5	SE
Tablet 8 mg	Oral	30	5	SE
Perindopril Erbumine with Indapamide Hemihydrate	Tablet 4 mg-1.25 mg	Oral	30	5	SE
Permethrin	Cream 50 mg per g, 30 g	Application	1	1	PC
Pethidine Hydrochloride	Injection 50 mg in 1 mL ampoule	Injection	5	..	MX
Injection 100 mg in 2 mL ampoule	Injection	5	..	MX
Phenelzine Sulfate	Tablet equivalent to 15 mg phenelzine	Oral	100	1	LM
"Phenex-1"	Oral powder 350 g	Oral	8	5	AB
Oral powder 400 g	Oral	8	5	AB
"Phenex-2"	Oral powder 325 g	Oral	10	5	AB
Oral powder 400 g	Oral	8	5	AB
Phenobarbitone	Tablet 30 mg	Oral	200	4	SI
Phenobarbitone Sodium	Injection 200 mg in 1 mL ampoule	Injection	5	..	FM
Phenoxybenzamine Hydrochloride	Capsule 10 mg	Oral	100	5	LM
Phenoxymethylpenicillin Benzathine	Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL	Oral	2	..	FM, SI
Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL	Oral	2	..	FM, SI
Phenoxymethylpenicillin Potassium	Tablet equivalent to 250 mg phenoxymethylpenicillin	Oral	50	..	SI
Tablet equivalent to 500 mg phenoxymethylpenicillin	Oral	50	..	SI
Capsule equivalent to 250 mg phenoxymethylpenicillin	Oral	50	..	CS, DP, FM, HX
Capsule equivalent to 500 mg phenoxymethylpenicillin	Oral	50	..	CS, DP, FM, HX
Phenytoin	Tablet 50 mg	Oral	200	2	PF
Oral suspension 30 mg per 5 mL, 500 mL	Oral	1	3	PF
Phenytoin Sodium	Capsule 30 mg	Oral	200	2	PF
Capsule 100 mg	Oral	200	2	PF
"Phlexy-10"	Capsules 500 mg, 200	Oral	16	5	SB
Tablets 1 g, 75	Oral	24	5	SB
Bars 42 g, 20	Oral	10	5	SB
"Phlexy-10 Drink Mix"	Sachets containing oral powder 20 g, 30	Oral	7	5	SB
Pilocarpine Hydrochloride	Eye drops 5 mg per mL, 15 mL	Application to the eye	1	5	AG, PE
Eye drops 10 mg per mL, 15 mL	Application to the eye	1	5	AG, AQ, PE
Eye drops 20 mg per mL, 15 mL	Application to the eye	1	5	AG, AQ, PE
Eye drops 30 mg per mL, 15 mL	Application to the eye	1	5	AG, AQ, PE
Eye drops 40 mg per mL, 15 mL	Application to the eye	1	5	AG, AQ, PE
Eye drops 60 mg per mL, 15 mL	Application to the eye	1	5	AG, PE
Pimecrolimus	Cream 10 mg per g, 15 g	Application	1	1	NV
Pindolol	Tablet 5 mg	Oral	100	5	AF, NV
Tablet 15 mg	Oral	50	5	AF, NV
Pioglitazone Hydrochloride	Tablet equivalent to 15 mg pioglitazone	Oral	28	5	LY
Tablet equivalent to 30 mg pioglitazone	Oral	28	5	LY
Tablet equivalent to 45 mg pioglitazone	Oral	28	5	LY
Piperazine Oestrone Sulfate	Tablet 730 micrograms	Oral	56	2	KR, PH
Tablet 1.46 mg	Oral	56	2	KR, PH
Piroxicam	Dispersible tablet 10 mg	Oral	50	3	AF, GX, HX, PF
Dispersible tablet 20 mg	Oral	25	3	AF, CH, GX, HX, PF, TW
Capsule 10 mg	Oral	50	3	AF, CH, GX, PF, TW
Capsule 20 mg	Oral	25	3	AF, CH, GX, PF, TW
Pizotifen Malate	Tablet equivalent to 500 micrograms pizotifen	Oral	100	2	NV
"PK AID II"	Oral powder 250 g	Oral	8	5	SB
"PK Max"	Sachets containing oral powder 19 g, 30	Oral	4	5	SB
"PKU Express Liquid"	Oral liquid 130 mL, 30	Oral	4	5	VF
"PKU-gel"	Sachets containing oral powder 20 g, 30	Oral	4	5	VF
"PKU-Express"	Sachets containing oral powder 25 g, 30	Oral	4	5	VF
Pneumococcal Vaccine - Polyvalent	Injection 0.5 mL vial (23 valent)	Injection	1	..	CS
Polyethylene Glycol 400 with Propylene Glycol	Eye drops 4 mg-3 mg per mL, 15 mL	Application to the eye	1	5	AQ
Polygeline	I.V. infusion 17.5 g per 500 mL with electrolytes, 500 mL	Injection	3	..	AE
Polymyxin B Sulfate with Bacitracin Zinc and Neomycin Sulfate	Eye ointment 5,000 units-400 units-5 mg per g, 4 g	Application to the eye	1	..	PC
Polyvinyl Alcohol	Eye drops 14 mg per mL, 15 mL	Application to the eye	1	5	AG, PE
Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)	Application to the eye	1	5	AE
Eye drops 30 mg per mL, 15 mL	Application to the eye	1	5	AG, PE
Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)	Application to the eye	1	5	AE
Potassium Chloride	Tablet 600 mg (sustained release)	Oral	200	1	AS, NV, SZ
Potassium Chloride with Potassium Bicarbonate	Tablet, effervescent, 14 mmol K+ and 8 mmol Cl-	Oral	60	1	AS, LN
Pravastatin Sodium	Tablet 10 mg	Oral	30	5	AW, BQ
Tablet 20 mg	Oral	30	5	AW, BQ
Tablet 40 mg	Oral	30	5	AW, BQ
Tablet 80 mg	Oral	30	5	AW, BQ
Prazosin Hydrochloride	Tablet equivalent to 1 mg prazosin	Oral	100	5	AF, CH, GX, HX, PF, TW
Tablet equivalent to 2 mg prazosin	Oral	100	5	AF, CH, GX, HX, PF, TW
Tablet equivalent to 5 mg prazosin	Oral	100	5	AF, CH, GX, HX, PF, TW
Prednisolone	Tablet 1 mg	Oral	100	4	AS, LN
Tablet 5 mg	Oral	60	4	AS, FM
Tablet 25 mg	Oral	30	4	AS, FM
Prednisolone Acetate with Phenylephrine Hydrochloride	Eye drops 10 mg-1.2 mg per mL, 10 mL	Application to the eye	1	2	AG
Prednisolone Sodium Phosphate	Oral solution equivalent to 5 mg prednisolone per mL, 30 mL	Oral	1	5	AS, LN
Enema, retention, equivalent to 20 mg prednisolone in 100 mL	Rectal	28	3	SI
Suppositories equivalent to 5 mg prednisolone, 10	Rectal	3	3	SI
Prednisone	Tablet 1 mg	Oral	100	4	AS, LN
Tablet 5 mg	Oral	60	4	AS, FM
Tablet 25 mg	Oral	30	4	AS, FM
Primidone	Tablet 250 mg	Oral	200	2	LM
"Pro-Phree"	Oral powder 400 g	Oral	8	5	AB
Probenecid	Tablet 500 mg	Oral	100	5	PL
Procaine Penicillin	Injection 1.5 g in disposable syringe	Injection	5	..	SI
Prochlorperazine	Suppositories 3 mg, equivalent to 5 mg prochlorperazine maleate, 5	Rectal	1	2	AV
Suppositories 15 mg, equivalent to 25 mg prochlorperazine maleate, 5	Rectal	1	2	AV
Prochlorperazine Maleate	Tablet 5 mg	Oral	25	..	AV, HP
Prochlorperazine Mesylate	Injection 12.5 mg in 1 mL ampoule	Injection	10	..	AV
Promethazine Hydrochloride	Injection 50 mg in 2 mL ampoule	Injection	10	..	MX
Propantheline Bromide	Tablet 15 mg	Oral	200	5	SI
Propranolol Hydrochloride	Tablet 10 mg	Oral	100	5	AF, AP
Tablet 40 mg	Oral	100	5	AF, AP
Tablet 160 mg	Oral	50	5	AF
Propylthiouracil	Tablet 50 mg	Oral	200	2	PL
Pyrantel Embonate	Tablet equivalent to 125 mg pyrantel	Oral	6	..	AF
Tablet equivalent to 250 mg pyrantel	Oral	6	..	AF
Pyridostigmine Bromide	Tablet 10 mg	Oral	100	5	VT
Tablet 60 mg	Oral	150	5	VT
Tablet 180 mg (modified release)	Oral	100	5	VT
Pyrimethamine	Tablet 25 mg	Oral	50	..	GK
Quetiapine Fumarate	Tablet equivalent to 25 mg quetiapine	Oral	60	5	AP
Tablet equivalent to 100 mg quetiapine	Oral	90	5	AP
Tablet equivalent to 200 mg quetiapine	Oral	60	5	AP
Tablet equivalent to 300 mg quetiapine	Oral	60	5	AP
Quinagolide Hydrochloride	Pack containing 3 tablets equivalent to 25 micrograms quinagolide and 3 tablets equivalent to 50 micrograms quinagolide	Oral	1	..	FP
Tablet equivalent to 75 micrograms quinagolide	Oral	30	5	FP
Quinapril Hydrochloride	Tablet equivalent to 5 mg quinapril	Oral	30	5	PF, SI
Tablet equivalent to 10 mg quinapril	Oral	30	5	PF, SI
Tablet equivalent to 20 mg quinapril	Oral	30	5	PF, SI
Quinapril Hydrochloride with Hydrochlorothiazide	Tablet equivalent to 10 mg quinapril with 12.5 mg hydrochlorothiazide	Oral	30	5	PF
Tablet equivalent to 20 mg quinapril with 12.5 mg hydrochlorothiazide	Oral	30	5	PF
Quinidine Bisulfate	Tablet 250 mg (sustained release)	Oral	100	5	AP
Quinine Bisulfate	Tablet 300 mg	Oral	50	2	AS
Quinine Sulfate	Tablet 300 mg	Oral	50	2	AS, LN
Rabeprazole Sodium	Tablet 20 mg (enteric coated)	Oral	30	2	JC
Tablet 10 mg (enteric coated)	Oral	28	5	JC
Raloxifene Hydrochloride	Tablet 60 mg	Oral	28	5	LY
Raltitrexed	Powder for I.V. infusion 2 mg in single use vial	Injection	3	2	AP
Ramipril	Tablet 1.25 mg	Oral	30	5	AV, ML
Tablet 2.5 mg	Oral	30	5	AV, ML
Tablet 5 mg	Oral	30	5	AV, ML
Capsule 10 mg	Oral	30	5	AV
Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg	Oral	1	..	AV
Ranitidine Hydrochloride	Tablet equivalent to 150 mg ranitidine	Oral	60	5	AF, CH, DP, GK, GX, HX, SI, TW
Tablet, effervescent, equivalent to 150 mg ranitidine	Oral	60	5	GK
Tablet equivalent to 300 mg ranitidine	Oral	30	5	AF, CH, DP, GK, GX, HX, SI, TW
Syrup equivalent to 150 mg ranitidine per 10 mL, 300 mL	Oral	2	5	GK
"RCF"	Oral liquid 384 mL	Oral	120	5	AB
Reboxetine Mesilate	Tablet equivalent to 4 mg reboxetine	Oral	60	5	PH
Reteplase	Pack containing 2 vials powder for injection 10 units, 2 single use pre-filled syringes with solvent, 2 reconstitution spikes and 2 needles	Injection	1	..	RO
Rifampicin	Capsule 150 mg	Oral	10	..	AF
Capsule 300 mg	Oral	10	..	AF
Syrup 100 mg per 5 mL, 60 mL	Oral	1	..	AV
Riluzole	Tablet 50 mg	Oral	56	5	AV
Risedronate Sodium	Tablet 5 mg	Oral	28	5	AV
Tablet 35 mg	Oral	4	5	AV
Tablet 30 mg	Oral	28	1	AV
Risperidone	Tablet 0.5 mg	Oral	60	2	JC
Tablet 0.5 mg (orally disintegrating)	Oral	56	2	JC
Tablet 1 mg	Oral	60	2	JC
Tablet 1 mg (orally disintegrating)	Oral	56	2	JC
Tablet 2 mg	Oral	60	5	JC
Tablet 2 mg (orally disintegrating)	Oral	56	5	JC
Tablet 3 mg	Oral	60	5	JC
Tablet 4 mg	Oral	60	5	JC
Oral solution 1 mg per mL, 30 mL	Oral	1	2	JC
Oral solution 1 mg per mL, 100 mL	Oral	1	5	JC
I.M. injection (modified release), set containing 1 vial powder for injection 25 mg, 1 pre-filled syringe diluent 2 mL and 3 needles	Injection	2	5	JC
I.M. injection (modified release), set containing 1 vial powder for injection 37.5 mg, 1 pre-filled syringe diluent 2 mL and 3 needles	Injection	2	5	JC
I.M. injection (modified release), set containing 1 vial powder for injection 50 mg, 1 pre-filled syringe diluent 2 mL and 3 needles	Injection	2	5	JC
Rituximab	Solution for I.V. infusion 100 mg in 10 mL vial	Injection	2	3	RO
Solution for I.V. infusion 500 mg in 50 mL vial	Injection	1	3	RO
Rivastigmine Hydrogen Tartrate	Capsule equivalent to 1.5 mg rivastigmine	Oral	56	5	NV
Capsule equivalent to 3 mg rivastigmine	Oral	56	5	NV
Capsule equivalent to 4.5 mg rivastigmine	Oral	56	5	NV
Capsule equivalent to 6 mg rivastigmine	Oral	56	5	NV
Oral solution equivalent to 2 mg rivastigmine per mL, 120 mL	Oral	1	5	NV
Rosiglitazone Maleate	Tablet equivalent to 4 mg rosiglitazone	Oral	28	5	GK
Tablet equivalent to 8 mg rosiglitazone	Oral	28	5	GK
Roxithromycin	Tablet for oral suspension 50 mg	Oral	10	1	AV
Tablet 150 mg	Oral	10	1	AV, HP
Tablet 300 mg	Oral	5	1	AV, HP
"S-26 LF"	Infant formula powder 900 g	Oral	5	..	WY
Salbutamol Sulfate	Oral solution equivalent to 2 mg salbutamol per 5 mL, 150 mL	Oral	2	5	GK
Capsule containing powder for oral inhalation equivalent to 200 micrograms salbutamol (for use in Ventolin Rotahaler)	Inhalation by mouth	200	5	GK
Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	2	5	AL, AW, GK, MM
Pressurised inhalation in breath actuated device equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	2	5	MM
Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30	Inhalation	2	5	AF, AW, CH, GK, GX, PU, TW
Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30	Inhalation	2	5	AF, AW, CH, GK, GX, TW
Nebuliser solution equivalent to 5 mg salbutamol per mL, 30 mL	Inhalation	2	2	PU
Salcatonin	Injection 50 I.U. in 1 mL ampoule	Injection	30	5	NV
Injection 100 I.U. in 1 mL ampoule	Injection	15	5	NV
Salmeterol Xinafoate	Pressurised inhalation equivalent to 25 micrograms salmeterol per dose, 120 doses	Inhalation by mouth	1	5	GK
Powder for oral inhalation in breath actuated device equivalent to 50 micrograms salmeterol per dose, 60 doses	Inhalation by mouth	1	5	GK
Selegiline Hydrochloride	Tablet 5 mg	Oral	100	5	AF, DP
Sertraline Hydrochloride	Tablet equivalent to 50 mg sertraline	Oral	30	5	AF, AW, CH, DP, GX, HX, PF, TW
Tablet equivalent to 100 mg sertraline	Oral	30	5	AF, AW, CH, DP, GX, HX, PF, TW
Silver Sulfadiazine with Chlorhexidine Gluconate	Cream 10 mg-2 mg per g, 50 g	Application	1	..	SN
Silver Sulfadiazine with Chlorhexidine Gluconate	Cream 10 mg-2 mg per g, 100 g	Application	1	..	SN
Simvastatin	Tablet 5 mg	Oral	30	5	AD, AF, BF, HX, MK, RE
Tablet 10 mg	Oral	30	5	AD, AF, AW, BF, CH, DP, GX, HX, MK, RE, TW
Tablet 20 mg	Oral	30	5	AD, AF, AW, BF, CH, DP, GX, HX, MK, RE, TW
Tablet 40 mg	Oral	30	5	AD, AF, AW, BF, CH, DP, GX, HX, MK, RE, TW
Tablet 80 mg	Oral	30	5	AD, AF, AW, BF, CH, DP, GX, HX, MK, RE, TW
Sirolimus	Tablet 1 mg	Oral	100	3	WY
Tablet 2 mg	Oral	100	3	WY
Oral solution 1 mg per mL, 60 mL	Oral	1	3	WY
Sodium Acid Phosphate	Tablet, compound effervescent, equivalent to 500 mg phosphorus	Oral	100	5	NV
Sodium Alginate with Calcium Carbonate and Sodium Bicarbonate	Oral liquid 1 g-320 mg-534 mg in 20 mL, 500 mL	Oral	2	5	RC
Sodium Aurothiomalate	Injection 10 mg ampoule	Injection	10	..	AV
Injection 20 mg ampoule	Injection	10	1	AV
Injection 50 mg ampoule	Injection	10	1	AV
Sodium Chloride	I.V. infusion 154 mmol per L, 1 L	Injection	5	1	BX
I.V. infusion 513 mmol per L, 1 L	Injection	2	1	BX
Sodium Chloride with Glucose	I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L	Injection	5	1	BX
I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL	Injection	5	1	BX
I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL	Injection	5	1	BX
Sodium Chloride with Potassium Chloride and Calcium Chloride	I.V. infusion containing approximately 148 mmol Na+, 4 mmol K+, 2 mmol Ca2+ and 156 mmol Cl- per L, 1 L	Injection	4	1	BX
Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride	Electrolyte replacement solution 5.26 g-3.68 g-5.02 g- 370 mg-300 mg per L, 1 L	Injection	2	1	BX
Sodium Clodronate Tetrahydrate	Capsule equivalent to 400 mg sodium clodronate	Oral	100	2	SC
Tablet equivalent to 800 mg sodium clodronate	Oral	60	2	SC
Sodium Cromoglycate	Capsule containing powder for oral inhalation 20 mg (for use in Intal Spinhaler or Intal Halermatic)	Inhalation by mouth	100	5	DP
Solution for inhalation 20 mg in 2 mL ampoule	Inhalation	120	3	AV
Pressurised inhalation 1 mg per dose, 200 doses	Inhalation by mouth	1	5	AV
Pressurised inhalation 1 mg per dose, 200 doses (CFC-free formulation)	Inhalation by mouth	1	5	AV
Pressurised inhalation 5 mg per dose, 112 doses (CFC-free formulation)	Inhalation by mouth	1	5	AV
Eye drops 20 mg per mL, 10 mL	Application to the eye	1	5	AV
Sodium Fusidate	Tablet 250 mg	Oral	36	1	CS
Sodium Lactate with Sodium Chloride, Potassium Chloride and Calcium Chloride	I.V. infusion containing approximately 131 mmol Na+, 5 mmol K+, 2 mmol Ca2+, 29 mmol HCO3- (as lactate) and 111 mmol Cl- per L, 1 L	Injection	5	1	BX
Sodium Valproate	Tablet, crushable, 100 mg	Oral	200	2	SW
Tablet 200 mg (enteric coated)	Oral	200	2	AF, SW
Tablet 500 mg (enteric coated)	Oral	200	2	AF, SW
Oral liquid 200 mg per 5 mL, 300 mL	Oral	2	2	SW
Oral solution 200 mg per 5 mL, 300 mL	Oral	2	2	SW
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate	Enemas 3.125 g-450 mg-45 mg in 5 mL, 12	Rectal	2	2	PH
Sotalol Hydrochloride	Tablet 80 mg	Oral	60	5	AW, BQ, GX, HX
Tablet 160 mg	Oral	60	5	AF, AW, BQ, CH, DP, GX, HX, TW
Spironolactone	Tablet 25 mg	Oral	100	5	AF, PH
Tablet 100 mg	Oral	100	5	AF, PH
Sterculia with Frangula Bark	Granules 620 mg-80 mg per g, 500 g	Oral	1	1	NE
Sucralfate	Tablet equivalent to 1 g anhydrous sucralfate	Oral	120	2	AF, AS
Sulfacetamide Sodium	Eye drops 100 mg per mL, 15 mL	Application to the eye	1	2	AG
Sulfasalazine	Tablet 500 mg	Oral	200	5	PH
Tablet 500 mg (enteric coated)	Oral	200	5	KR, PH
Sulindac	Tablet 100 mg	Oral	100	3	AF
Tablet 200 mg	Oral	50	3	AF
Sulthiame	Tablet 50 mg	Oral	200	2	PL
Tablet 200 mg	Oral	200	2	PL
Sumatriptan	Nasal spray 20 mg in 0.1 mL single dose unit	Nasal	2	5	GK
Sumatriptan Succinate	Tablet equivalent to 50 mg sumatriptan	Oral	4	5	AW, GK
Tacrolimus	Capsule 500 micrograms	Oral	100	3	JC
Capsule 1 mg	Oral	100	3	JC
Capsule 5 mg	Oral	50	3	JC
Tamoxifen Citrate	Tablet equivalent to 10 mg tamoxifen	Oral	60	5	AF, AP, DP, HX
Tablet equivalent to 20 mg tamoxifen	Oral	60	5	AF, AP, CH, DP, GX, HX, SI, TW
Telmisartan	Tablet 40 mg	Oral	28	5	BY
Tablet 80 mg	Oral	28	5	BY
Telmisartan with Hydrochlorothiazide	Tablet 40 mg-12.5 mg Tablet 80 mg-12.5 mg	Oral Oral	28 28	5 5	BY BY
Temazepam	Tablet 10 mg	Oral	25	..	AF, FM, SI
Temozolomide	Capsule 5 mg	Oral	15	2	SH
Capsule 20 mg	Oral	15	2	SH
Capsule 100 mg	Oral	15	2	SH
Capsule 250 mg	Oral	5	5	SH
Tenecteplase	Powder for injection 40 mg vial with solvent	Injection	1	..	BY
Powder for injection 50 mg vial with solvent	Injection	1	..	BY
Terbinafine Hydrochloride	Tablet equivalent to 250 mg terbinafine	Oral	42	1	AF, AW, DP, GX, HX, NV
Terbutaline Sulfate	Injection 500 micrograms in 1 mL ampoule	Injection	5	..	AP
Powder for oral inhalation in breath actuated device 500 micrograms per dose, 200 doses	Inhalation by mouth	1	5	AP
Nebuliser solution 5 mg in 2 mL single dose units, 30	Inhalation	2	5	AP
Testosterone	Subcutaneous implant 100 mg	Subcutaneous implantation	6	..	OR
Subcutaneous implant 200 mg	Subcutaneous implantation	3	..	OR
Transdermal gel 50 mg in 5 g sachet, 30	Transdermal	1	5	SC
Transdermal patches 12.2 mg, 60	Transdermal	1	5	MX
Transdermal patches 24.3 mg, 30	Transdermal	1	5	MX
Testosterone Enanthate	Injection 250 mg in 1 mL	Injection	3	3	SC
Testosterone Propionate with Testosterone Phenylpropionate and Testosterone Isocaproate	Injection 20 mg-40 mg-40 mg in 1 mL ampoule	Injection	3	3	OR
Testosterone Propionate with Testosterone Phenylpropionate, Testosterone Isocaproate and Testosterone Decanoate	Injection 30 mg-60 mg-60 mg-100 mg in 1 mL ampoule	Injection	3	3	OR
Testosterone Undecanoate	Capsule 40 mg	Oral	60	5	OR
Tetanus Vaccine - Adsorbed	Injection 0.5 mL in pre-filled syringe	Injection	3	..	CS
Tetrabenazine	Tablet 25 mg	Oral	112	5	OA
Tetracosactrin	Compound depot injection 1 mg in 1 mL ampoule	Injection	5	5	NV
Theophylline	Tablet 125 mg	Oral	100	5	MM
Tablet 200 mg (sustained release)	Oral	100	5	MM
Tablet 250 mg (sustained release)	Oral	100	5	MM
Tablet 300 mg (sustained release)	Oral	100	5	MM
Oral solution 133.3 mg per 25 mL, 500 mL	Oral	1	5	MM
Thioguanine	Tablet 40 mg	Oral	25	1	GK
Thioridazine Hydrochloride	Tablet 10 mg	Oral	100	5	AF
Tablet 25 mg	Oral	100	5	AF
Tablet 50 mg	Oral	100	5	AF
Tablet 100 mg	Oral	100	5	AF
Thiotepa	Powder for injection 15 mg	Injection or intravesical administration	2	1	SI
Thyroxine Sodium	Tablet equivalent to 50 micrograms anhydrous thyroxine sodium	Oral	200	1	FM, SI
Tablet equivalent to 100 micrograms anhydrous thyroxine sodium	Oral	200	1	FM, SI
Tablet equivalent to 200 micrograms anhydrous thyroxine sodium	Oral	200	1	FM, SI
Tiagabine Hydrochloride	Tablet equivalent to 5 mg tiagabine	Oral	100	5	MX
Tablet equivalent to 10 mg tiagabine	Oral	100	5	MX
Tablet equivalent to 15 mg tiagabine	Oral	100	5	MX
Tiaprofenic Acid	Tablet 300 mg	Oral	60	3	AV
Ticarcillin Sodium with Potassium Clavulanate	Powder for injection equivalent to 3 g ticarcillin-100 mg clavulanic acid	Injection	10	..	GK
Ticlopidine Hydrochloride	Tablet 250 mg	Oral	60	5	AF, HX, RO
Tiludronate Disodium	Tablet equivalent to 200 mg tiludronic acid	Oral	56	2	MX
Timolol Maleate	Eye gel equivalent to 1 mg timolol per g, 5 g	Application to the eye	1	5	NV
Eye drops equivalent to 2.5 mg timolol per mL, 5 mL	Application to the eye	1	5	FR, SI
Eye drops equivalent to 5 mg timolol per mL, 5 mL	Application to the eye	1	5	FR, SI
Eye drops (gellan gum solution) equivalent to 2.5 mg timolol per mL, 2.5 mL	Application to the eye	1	5	MK
Eye drops (gellan gum solution) equivalent to 5 mg timolol per mL, 2.5 mL	Application to the eye	1	5	MK
Tinidazole	Tablet 500 mg	Oral	4	..	GP, PF
Tiotropium Bromide Monohydrate	Capsule containing powder for oral inhalation equivalent to 18 micrograms tiotropium (for use in HandiHaler)	Inhalation by mouth	30	5	BY
Tirofiban Hydrochloride	Solution concentrate for I.V. infusion equivalent to 12.5 mg tirofiban in 50 mL vial	Injection	1	2	MK
Tobramycin	Eye drops 3 mg per mL, 5 mL	Application to the eye	1	2	AQ
Eye ointment 3 mg per g, 3.5 g	Application to the eye	1	..	AQ
Tobramycin Sulfate	Injection equivalent to 80 mg tobramycin in 2 mL (with preservative)	Injection	10	1	AS, MX
Injection equivalent to 80 mg tobramycin in 2 mL (without preservative)	Injection	10	1	PU
Topiramate	Tablet 25 mg	Oral	60	5	JC
Tablet 50 mg	Oral	60	5	JC
Tablet 100 mg	Oral	60	5	JC
Tablet 200 mg	Oral	60	5	JC
Capsule 15 mg	Oral	60	5	JC
Capsule 25 mg	Oral	60	5	JC
Capsule 50 mg	Oral	60	5	JC
Topotecan Hydrochloride	Powder for I.V. infusion equivalent to 4 mg topotecan, vial	Injection	5	1	GK
Toremifene Citrate	Tablet equivalent to 60 mg toremifene	Oral	30	5	SH
Tramadol Hydrochloride	Capsule 50 mg	Oral	20	..	AW, CH, CS, GX, TW
Tablet 100 mg (sustained release)	Oral	20	..	AW, CS, HX
Tablet 150 mg (sustained release)	Oral	20	..	AW, CS, HX
Tablet 200 mg (sustained release)	Oral	20	..	AW, CS, HX
Oral drops 100 mg per mL, 10 mL	Oral	1	..	CS
Injection 100 mg in 2 mL ampoule	Injection	5	..	CS
Trandolapril	Capsule 500 micrograms	Oral	28	5	AB, KN
Capsule 1 mg	Oral	28	5	AB, KN
Capsule 2 mg	Oral	28	5	AB, KN
Capsule 4 mg	Oral	28	5	AB
Tranexamic Acid	Tablet 500 mg	Oral	100	2	PH
Tranylcypromine Sulfate	Tablet equivalent to 10 mg tranylcypromine	Oral	50	2	LM
Travoprost	Eye drops 40 micrograms per mL, 2.5 mL	Application to the eye	1	5	AQ
Triamcinolone Acetonide	Injection 10 mg in 1 mL ampoule	Injection	5	..	BQ
Cream 200 micrograms per g, 100 g	Application	2	..	FM, SI
Ointment 200 micrograms per g, 100 g	Application	2	..	FM, SI
Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin	Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL	Application to the ear	1	2	BC, BQ
Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g	Application to the ear	1	2	BC, BQ
Trifluoperazine Hydrochloride	Tablet equivalent to 1 mg trifluoperazine	Oral	100	5	LM
Tablet equivalent to 2 mg trifluoperazine	Oral	100	5	LM
Tablet equivalent to 5 mg trifluoperazine	Oral	100	5	LM
Triglycerides Oil - Medium Chain	500 mL	Oral	2	5	SB
Trimethoprim	Tablet 300 mg	Oral	7	1	AF, SI
Trimethoprim with Sulfamethoxazole	Tablet 80 mg-400 mg Tablet 160 mg-800 mg	Oral Oral	10 10	1 1	AF, SI AF, CH, GX, RO, SI, TW
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL	Oral	1	1	AF, RO, SI
Tropisetron Hydrochloride	Capsule equivalent to 5 mg tropisetron	Oral	2	..	NV
I.V. injection equivalent to 5 mg tropisetron in 5 mL ampoule	Injection	1	..	NV
"TYR gel"	Sachets containing oral powder 20 g, 30	Oral	4	5	VF
"TYR Express"	Sachets containing oral powder 25 g, 30	Oral	4	5	VF
Ursodeoxycholic Acid	Capsule 250 mg	Oral	100	2	OA
Valaciclovir Hydrochloride	Tablet equivalent to 500 mg valaciclovir	Oral	20	..	GK
Vancomycin Hydrochloride	Capsule equivalent to 125 mg (125,000 I.U.) vancomycin activity	Oral	40	..	LY
Capsule equivalent to 250 mg (250,000 I.U.) vancomycin activity	Oral	40	..	LY
Powder for injection equivalent to 500 mg (500,000 I.U.) vancomycin activity	Injection	2	..	LY, MX
Venlafaxine Hydrochloride	Tablet equivalent to 37.5 mg venlafaxine	Oral	56	5	WY
Tablet equivalent to 75 mg venlafaxine	Oral	56	5	WY
Capsule (modified release) equivalent to 37.5 mg venlafaxine	Oral	28	..	WY
Capsule (modified release) equivalent to 75 mg venlafaxine	Oral	28	5	WY
Capsule (modified release) equivalent to 150 mg venlafaxine	Oral	28	5	WY
Verapamil Hydrochloride	Tablet 40 mg	Oral	100	5	AB, AF, HX
Tablet 80 mg	Oral	100	5	AB, AF, HX
Tablet 120 mg	Oral	100	5	AB, HX
Tablet 160 mg	Oral	60	5	AB
Tablet 180 mg (sustained release)	Oral	30	5	AB, KN
Tablet 240 mg (sustained release)	Oral	30	5	AB, AF, KN
Capsule 160 mg (sustained release)	Oral	30	5	SI
Capsule 240 mg (sustained release)	Oral	30	5	SI
Injection 5 mg in 2 mL ampoule	Injection	5	..	AB
Vigabatrin	Tablet 500 mg	Oral	100	5	AV
Oral powder, sachet 500 mg	Oral	60	5	AV
Vinblastine Sulfate	Powder for injection 10 mg	Injection	5	..	AS
Solution for I.V. injection 10 mg in 10 mL vial	Injection	5	..	MX
Vincristine Sulfate	I.V. injection 1 mg in 1 mL vial	Injection	10	..	MX, PU
Vinorelbine Tartrate	Solution for I.V. infusion equivalent to 10 mg vinorelbine in 1 mL vial	Injection	16	2	FB, MX
Solution for I.V. infusion equivalent to 50 mg vinorelbine in 5 mL vial	Injection	4	2	FB, MX
Warfarin Sodium	Tablet 1 mg	Oral	50	2	FM, SI
Tablet 2 mg	Oral	50	2	SI
Tablet 3 mg	Oral	50	2	FM
Tablet 5 mg	Oral	50	2	FM, SI
"XMET Analog"	Oral powder 400 g	Oral	8	5	SB
"XMET Maxamaid"	Oral powder 500 g	Oral	8	5	SB
"XMET Maxamum"	Oral powder 500 g	Oral	8	5	SB
"XMTVI Analog"	Oral powder 400 g	Oral	8	5	SB
"XMTVI Asadon"	Oral powder 200 g	Oral	5	5	SB
"XMTVI Maxamaid"	Oral powder 500 g	Oral	8	5	SB
"XMTVI Maxamum"	Oral powder 500 g	Oral	8	5	SB
"XP Analog"	Oral powder 400 g	Oral	8	5	SB
"XP Analog LCP"	Oral powder 400 g	Oral	8	5	SB
"XP Maxamaid"	Oral powder 500 g	Oral	8	5	SB
"XP Maxamum"	Sachets containing oral powder 50 g, 30	Oral	3	5	SB
Oral powder 500 g	Oral	8	5	SB
"XPhen, Tyr Analog"	Oral powder 400 g	Oral	8	5	SB
"XPhen, Tyr Maxamaid"	Oral powder 500 g	Oral	8	5	SB
"XPhen, Tyr Maxamum"	Oral powder 500 g	Oral	8	5	SB
"XPTM Tyrosidon"	Oral powder 500 g	Oral	4	5	SB
Zolmitriptan	Tablet 2.5 mg	Oral	4	5	AP
Zuclopenthixol Decanoate	Oily I.M. injection 200 mg in 1 mL ampoule	Injection	5	..	LU

Bisacodyl	Tablet 5 mg	Oral	200	..	AE, AS
Suppositories 10 mg, 10	Rectal	3	..	BY, PP
Suppositories 10 mg, 12	Rectal	3	..	FL, PP
Enemas 10 mg in 5 mL, 25	Rectal	1	..	AS
Carmellose Sodium	Mouth spray 10 mg per mL, 25 mL	Oral application	1	..	HA
Mouth spray 10 mg per mL, 100 mL	Oral application	1	..	HA
Clonazepam	Tablet 500 micrograms	Oral	100	..	AF, RO
Tablet 2 mg	Oral	100	..	AF, RO
Oral liquid 2.5 mg per mL, 10 mL	Oral	2	..	RO
Diazepam	Tablet 2 mg	Oral	50	..	AF, AW, RO, SU
Tablet 5 mg	Oral	50	..	AF, AW, DP, RO, SU
Diclofenac Sodium	Tablet 25 mg (enteric coated)	Oral	100	..	AF, AW, BG, CH, DP, GX, HX, NV, TW
Tablet 50 mg (enteric coated)	Oral	50	..	AF, AW, CH, DP, GX, HX, NV, TW
Suppository 100 mg	Rectal	40	..	NV
Docusate Sodium with Bisacodyl	Suppositories 100 mg-10 mg, 5	Rectal	6	..	FM
Glycerol	Suppositories 700 mg, 12	Rectal	3	..	PP
Suppositories 1.4 g, 12	Rectal	3	..	PP
Suppositories 2.8 g, 12	Rectal	3	..	PP
Hyoscine Butylbromide	Injection 20 mg in 1 mL ampoule	Injection	5	..	BY
Ibuprofen	Tablet 200 mg	Oral	100	..	AF
Tablet 400 mg	Oral	100	..	AB
Indomethacin	Capsule 25 mg	Oral	100	..	AF, MK
Suppository 100 mg	Rectal	40	..	MK
Naproxen	Tablet 250 mg	Oral	100	..	AF, RO
Tablet 500 mg	Oral	50	..	AF, RO
Tablet 750 mg (sustained release)	Oral	28	..	MD, RO
Tablet 1 g (sustained release)	Oral	28	..	MD, RO
Naproxen Sodium	Tablet 550 mg	Oral	50	..	MD, RO
Nitrazepam	Tablet 5 mg	Oral	50	..	AF, VT
Oxazepam	Tablet 15 mg	Oral	50	..	AF, SI
Tablet 30 mg	Oral	50	..	AF, FM, SI
Paracetamol	Tablet 665 mg (modified release)	Oral	96	..	GC, ME
Suppositories 500 mg, 24	Rectal	1	..	GC
Promethazine Hydrochloride	Tablet 10 mg	Oral	50	..	AV
Tablet 25 mg	Oral	50	..	AV
Oral liquid 5 mg per 5 mL, 100 mL	Oral	1	..	AV
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate	Enemas 3.125 g-450 mg-45 mg in 5 mL, 12	Rectal	2	..	PH
Sterculia with Frangula Bark	Granules 620 mg-80 mg per g, 500 g	Oral	1	..	NE
Sulindac	Tablet 100 mg	Oral	100	..	AF
Tablet 200 mg	Oral	50	..	AF
Temazepam	Tablet 10 mg	Oral	50	..	AF, FM, SI

Bisacodyl	Tablet 5 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	200	3	AE, AS
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppositories 10 mg, 10	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	3	3	BY, PP
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppositories 10 mg, 12	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	3	3	FL, PP
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Enemas 10 mg in 5 mL, 25	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	1	3	AS
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Carmellose Sodium	Mouth spray 10 mg per mL, 25 mL	In compliance with authority procedures set out in subparagraph 11 (d):	Oral application	1	3	HA
Initial supply, for up to 4 months, for palliative care patients where dry mouth is a symptom, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Mouth spray 10 mg per mL, 25 mL		Oral application
Continuing supply for palliative care patients where dry mouth is a symptom, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Mouth spray 10 mg per mL, 100 mL	In compliance with authority procedures set out in subparagraph 11 (d):	Oral application	1	3	HA
Mouth spray 10 mg per mL, 100 mL	Initial supply, for up to 4 months, for palliative care patients where dry mouth is a symptom, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Oral application
Continuing supply for palliative care patients where dry mouth is a symptom, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Clonazepam	Tablet 500 micrograms	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF, RO
Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 2 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF, RO
Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Oral liquid 2.5 mg per mL, 10 mL	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	2	3	RO
Oral liquid 2.5 mg per mL, 10 mL	Initial supply, for up to 4 months, for palliative care patients for the prevention of epilepsy, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients for the prevention of epilepsy, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Diazepam	Tablet 2 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, AW, RO, SU
Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life						AF, AW, RO, SU
Continuing supply for palliative care patients where anxiety is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 5 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, AW, DP, RO, SU
Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life					AF, AW, DP, RO, SU
Continuing supply for palliative care patients where anxiety is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Diclofenac Sodium	Tablet 25 mg (enteric coated)	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF, AW, BG, CH, DP, GX, HX, NV, TW
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Tablet 25 mg (enteric coated)					AF, AW, BG, CH, DP, GX, HX, NV, TW
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 50 mg (enteric coated)	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, AW, CH, DP, GX, HX, NV, TW
Tablet 50 mg (enteric coated)	Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life				AF, AW, CH, DP, GX, HX, NV, TW
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppository 100 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	40	3	NV
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Docusate Sodium with Bisacodyl	Suppositories 100 mg-10 mg, 5	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	6	3	FM
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Suppositories 100 mg-10 mg, 5
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Glycerol	Suppositories 700 mg, 12	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	3	3	PP
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppositories 1.4 g, 12	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	3	3	PP
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppositories 2.8 g, 12	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	3	3	PP
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Hyoscine Butylbromide	Injection 20 mg in 1 mL ampoule	In compliance with authority procedures set out in subparagraph 11 (d):	Injection	5	3	BY
Initial supply, for up to 4 months, for palliative care patients where colicky pain is a symptom, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Injection 20 mg in 1 mL ampoule
Continuing supply for palliative care patients where colicky pain is a symptom, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Ibuprofen	Tablet 200 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 400 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AB
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Indomethacin	Capsule 25 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF, MK
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppository 100 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	40	3	MK
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Naproxen	Tablet 250 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF, RO
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 500 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, RO
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 750 mg (sustained release)	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	28	3	MD, RO
Tablet 750 mg (sustained release)	Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 1 g (sustained release)	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	28	3	MD, RO
Tablet 1 g (sustained release)	Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Naproxen Sodium	Tablet 550 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	MD, RO
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Nitrazepam	Tablet 5 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, VT
Initial supply, for up to 4 months, for palliative care patients where insomnia is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where insomnia is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Oxazepam	Tablet 15 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, SI
Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where anxiety is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 30 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, FM, SI
Initial supply, for up to 4 months, for palliative care patients where anxiety is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where anxiety is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Paracetamol	Tablet 665 mg (modified release)	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	96	3	GC, ME
Initial supply, for up to 4 months, for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Tablet 665 mg (modified release)
Continuing supply for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Suppositories 500 mg, 24	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	1	3	GC
Initial supply, for up to 4 months, for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients for analgesia or fever where alternative therapy cannot be tolerated, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Promethazine Hydrochloride	Tablet 10 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AV
Initial supply, for up to 4 months, for palliative care patients where nausea or vomiting is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where nausea or vomiting is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 25 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AV
Initial supply, for up to 4 months, for palliative care patients where nausea or vomiting is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where nausea or vomiting is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Oral liquid 5 mg per 5 mL, 100 mL	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	1	3	AV
Oral liquid 5 mg per 5 mL, 100 mL	Initial supply, for up to 4 months, for palliative care patients where nausea or vomiting is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where nausea or vomiting is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate	Enemas 3.125 g-450 mg-45 mg in 5 mL, 12	In compliance with authority procedures set out in subparagraph 11 (d):	Rectal	2	3	PH
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate	Enemas 3.125 g-450 mg-45 mg in 5 mL, 12	Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Sterculia with Frangula Bark	Granules 620 mg-80 mg per g, 500 g	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	1	3	NE
Initial supply, for up to 4 months, for palliative care patients where constipation is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life	Granules 620 mg-80 mg per g, 500 g
Continuing supply for palliative care patients where constipation is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Sulindac	Tablet 100 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	100	3	AF
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Tablet 200 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF
Initial supply, for up to 4 months, for palliative care patients where severe pain is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where severe pain is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Temazepam	Tablet 10 mg	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	50	3	AF, FM, SI
Initial supply, for up to 4 months, for palliative care patients where insomnia is a problem, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life
Continuing supply for palliative care patients where insomnia is a problem, where consultation with a palliative care specialist or service has occurred, and where a palliative care patient is a patient with an active, progressive, far-advanced disease and for whom the prognosis is limited and the focus of care is the quality of life

Adrenaline Acid Tartrate	Injection equivalent to adrenaline 1 in 1,000, 1 mL	Injection	5	..	AP
Amoxycillin Trihydrate	Tablet, chewable, equivalent to 250 mg amoxycillin	Oral	20	..	GK
Capsule equivalent to 250 mg amoxycillin	Oral	20	..	AF, CH, CS, DG, DP, GK, GX, HX, SI, TW
Capsule equivalent to 500 mg amoxycillin	Oral	20	..	AF, CH, CS, DG, DP, GK, GX, HX, SI, TW
Sachet containing oral powder equivalent to 3 g amoxycillin	Oral	1	..	GK
Amoxycillin Trihydrate with Potassium Clavulanate	Tablet equivalent to 500 mg amoxycillin-125 mg clavulanic acid	Oral	10	..	AL, AW, GK, HX, SL, SZ
Tablet equivalent to 875 mg amoxycillin-125 mg clavulanic acid	Oral	10	..	AL, AW, CH, GK, GX, HX, SL, SZ, TW
Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP	Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL	Oral	1	..	AL, AW, GK, HX
Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL	Oral	1	..	AL, AW, GK, HX
Amoxycillin Trihydrate with Water - Purified BP	Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL	Oral	1	..	GK
Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL	Oral	1	..	AF, CH, CS, DP, GK, GX, HX, SI, TW
Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL	Oral	1	..	AF, CH, CS, DP, GK, GX, HX, SI, TW
Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL	Oral	1	..	SZ
Amphotericin	Lozenge 10 mg	Oral	20	..	BQ
Ampicillin Sodium	Powder for injection equivalent to 500 mg ampicillin	Injection	5	..	CS, DP
Ampicillin Sodium	Powder for injection equivalent to 1 g ampicillin	Injection	5	..	AS, CS, DP
Ampicillin Trihydrate	Capsule equivalent to 250 mg ampicillin	Oral	24	..	AF
Capsule equivalent to 500 mg ampicillin	Oral	24	..	AF
Aspirin	Tablet, dispersible, 300 mg	Oral	96	..	RC
Atropine Sulfate	Injection 600 micrograms in 1 mL ampoule	Injection	10	..	AP
Benzathine Penicillin	Injection 900 mg in 2 mL cartridge-needle unit (for use with Tubex Injector)	Injection	1	..	AS
Benztropine Mesylate	Injection 2 mg in 2 mL ampoule	Injection	5	..	MK
Benzydamine Hydrochloride	Mouth and throat rinse 22.5 mg per 15 mL, 500 mL	Oral application	1	..	MM
Benzylpenicillin Sodium	Powder for injection equivalent to 600 mg benzylpenicillin	Injection	10	..	CS
Benzylpenicillin Sodium	Powder for injection equivalent to 3 g benzylpenicillin	Injection	10	..	CS
Betamethasone Acetate with Betamethasone Sodium Phosphate	Injection 3 mg-3.9 mg in 1 mL ampoule	Injection	5	..	SH
Carbamazepine	Tablet 100 mg	Oral	200	..	BG, NV, SZ
Tablet 200 mg	Oral	200	..	AF, BG, NV, SZ
Tablet 200 mg (controlled release)	Oral	200	..	NV
Tablet 400 mg (controlled release)	Oral	200	..	NV
Oral suspension 100 mg per 5 mL, 300 mL	Oral	1	..	NV
Cefaclor Monohydrate	Tablet (sustained release) equivalent to 375 mg cefaclor	Oral	10	..	AF, AS, CH, DG, DP, GX, LN, TW
Cefaclor Monohydrate with Water - Purified BP	Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL	Oral	1	..	AF, AS, AW, CH, GX, TW
Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL	Oral	1	..	AF, AS, AW, CH, GX, TW
Cefotaxime Sodium	Powder for injection equivalent to 1 g cefotaxime	Injection	10	..	MX, SZ
Cefotaxime Sodium	Powder for injection equivalent to 2 g cefotaxime	Injection	10	..	MX, SZ
Cefuroxime Axetil	Tablet equivalent to 250 mg cefuroxime	Oral	14	..	GK
Cephalexin	Capsule 250 mg (anhydrous)	Oral	20	..	AF, AS, CH, DP, GX, HX, LN, TW
Capsule 500 mg (anhydrous)	Oral	20	..	AF, AS, CH, DP, GX, HX, LN, TW
Cephalexin with Water - Purified BP	Granules for oral suspension 125 mg per 5 mL, 100 mL	Oral	1	..	AF, AS, CH, DP, GX, LN, TW
Granules for oral suspension 250 mg per 5 mL, 100 mL	Oral	1	..	AF, AS, CH, DP, GX, LN, TW
Cephalothin Sodium	Powder for injection equivalent to 1 g cephalothin	Injection	10	..	LY, MX
Chloramphenicol	Eye drops 5 mg per mL, 10 mL	Application to the eye	1	..	PF, SI
Clindamycin Hydrochloride	Capsule equivalent to 150 mg clindamycin	Oral	25	..	KR, PH
Codeine Phosphate	Tablet 30 mg	Oral	20	..	FM
Codeine Phosphate with Paracetamol	Tablet 30 mg-500 mg	Oral	20	..	AL, CO, DK, FM, GK, SW
Diazepam	Tablet 2 mg	Oral	50	..	AF, AW, RO, SU
Tablet 5 mg	Oral	50	..	AF, AW, DP, RO, SU
Injection 10 mg in 2 mL ampoule	Injection	5	..	MX
Diclofenac Sodium	Tablet 25 mg (enteric coated)	Oral	100	..	AF, AW, BG, CH, DP, GX, HX, NV, TW
Tablet 50 mg (enteric coated)	Oral	50	..	AF, AW, CH, DP, GX, HX, NV, TW
Suppository 100 mg	Rectal	40	..	NV
Dicloxacillin Sodium	Capsule equivalent to 250 mg dicloxacillin	Oral	24	..	AF, BQ, SI
Capsule equivalent to 500 mg dicloxacillin	Oral	24	..	AF, BQ, SI
Powder for injection equivalent to 500 mg dicloxacillin	Injection	5	..	BQ
Powder for injection equivalent to 1 g dicloxacillin	Injection	5	..	BQ
Diflunisal	Tablet 250 mg	Oral	100	..	MK
Tablet 500 mg	Oral	50	..	MK
Doxycycline Hydrochloride	Tablet equivalent to 100 mg doxycycline	Oral	7	..	AF, DP, PF, SI
Capsule equivalent to 100 mg doxycycline (containing enteric coated pellets)	Oral	7	..	FA, MX
Doxycycline Monohydrate	Tablet equivalent to 100 mg doxycycline	Oral	7	..	CH, GX, HX, TW
Erythromycin	Capsule 250 mg (containing enteric coated pellets)	Oral	25	..	FA, MX
Erythromycin Ethyl Succinate	Tablet equivalent to 400 mg erythromycin	Oral	25	..	AB, AF
Erythromycin Ethyl Succinate with Water - Purified BP	Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL	Oral	1	..	AB, AF
Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL	Oral	1	..	AB, AF
Erythromycin Lactobionate	Powder for I.V. infusion equivalent to 1 g erythromycin, vial	Injection	5	..	AB
Flucloxacillin Magnesium with Water - Purified BP	Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL	Oral	1	..	CS, GK
Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL	Oral	1	..	CS, GK
Flucloxacillin Sodium	Capsule equivalent to 250 mg flucloxacillin	Oral	24	..	AF, CS, GK, SI
Capsule equivalent to 500 mg flucloxacillin	Oral	24	..	AF, CS, GK, SI
Powder for injection equivalent to 500 mg flucloxacillin	Injection	5	..	CS, DP
Powder for injection equivalent to 1 g flucloxacillin	Injection	5	..	AS, CS, DP, MX
Glucagon Hydrochloride	Injection set containing 1 mg (1 I.U.) and 1 mL solvent in disposable syringe	Injection	1	..	NO
Glucose	I.V. infusion 278 mmol (anhydrous) per L, 1 L	Injection	5	..	BX
Glyceryl Trinitrate	Tablets 600 micrograms, 100	Oral	1	..	FM, LM, SI
Hydrocortisone Acetate	Cream 10 mg per g, 30 g	Application	1	..	FM, SI
Cream 10 mg per g, 50 g	Application	1	..	DT, FM, SI
Ointment 10 mg per g, 30 g	Application	1	..	FM, SI
Ointment 10 mg per g, 50 g	Application	1	..	FM, SI
Hydrocortisone Sodium Succinate	Injection equivalent to 100 mg hydrocortisone with 2 mL solvent	Injection	6	..	PH
Injection equivalent to 250 mg hydrocortisone with 2 mL solvent	Injection	6	..	PH
Hydromorphone Hydrochloride	Tablet 2 mg	Oral	20	..	AB
Tablet 4 mg	Oral	20	..	AB
Tablet 8 mg	Oral	20	..	AB
Oral liquid 1 mg per mL, 473 mL	Oral	1	..	AB
Injection 2 mg in 1 mL ampoule	Injection	5	..	AB
Injection 10 mg in 1 mL ampoule	Injection	5	..	AB
Injection 50 mg in 5 mL ampoule	Injection	5	..	AB
Ibuprofen	Tablet 200 mg	Oral	100	..	AF
Tablet 400 mg	Oral	100	..	AB
Tablets 400 mg, 20	Oral	1	..	AB
Indomethacin	Capsule 25 mg	Oral	100	..	AF, MK
Suppository 100 mg	Rectal	40	..	MK
Ketoprofen	Capsule 200 mg (sustained release)	Oral	28	..	AV, HP
Suppository 100 mg	Rectal	40	..	AV
Lignocaine Hydrochloride	Injection 100 mg in 5 mL	Injection	5	..	PF
Lincomycin Hydrochloride	Injection equivalent to 600 mg lincomycin in 2 mL vial	Injection	5	..	PH
Methylprednisolone Acetate	Injection 40 mg in 1 mL vial	Injection	5	..	KR, PH
Metoclopramide Hydrochloride	Tablet 10 mg	Oral	25	..	AF, VT
Oral solution 5 mg per 5 mL, 100 mL	Oral	1	..	VT
Injection 10 mg in 2 mL ampoule	Injection	10	..	VT
Metronidazole	Tablet 200 mg	Oral	21	..	AF, AV, HP
Tablet 400 mg	Oral	5	..	AF
I.V. infusion 500 mg in 100 mL	Injection	5	..	BX
Suppositories 500 mg, 10	Rectal	1	..	AV
Metronidazole Benzoate	Oral suspension 320 mg per 5 mL, 100 mL	Oral	1	..	AV
Morphine Hydrochloride	Oral solution 2 mg per mL, 200 mL	Oral	1	..	MF
Oral solution 5 mg per mL, 200 mL	Oral	1	..	MF
Oral solution 10 mg per mL, 200 mL	Oral	1	..	MF
Morphine Sulfate	Tablet 30 mg	Oral	20	..	FM
Tablet 5 mg (controlled release)	Oral	20	..	MF
Tablet 10 mg (controlled release)	Oral	20	..	MF
Tablet 15 mg (controlled release)	Oral	20	..	MF
Tablet 30 mg (controlled release)	Oral	20	..	MF
Tablet 60 mg (controlled release)	Oral	20	..	MF
Tablet 100 mg (controlled release)	Oral	20	..	MF
Capsule 10 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 20 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 30 mg (controlled release)	Oral	10	..	MF
Capsule 50 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 60 mg (controlled release)	Oral	10	..	MF
Capsule 90 mg (controlled release)	Oral	10	..	MF
Capsule 100 mg (containing sustained release pellets)	Oral	20	..	GK
Capsule 120 mg (controlled release)	Oral	10	..	MF
Sachet containing controlled release granules for oral suspension, 20 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 30 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 60 mg per sachet	Oral	20	..	MF
Sachet containing controlled release granules for oral suspension, 100 mg per sachet	Oral	20	..	MF
Injection 10 mg in 1 mL ampoule	Injection	5	..	MX, SI
Injection 15 mg in 1 mL ampoule	Injection	5	..	MX, SI
Injection 30 mg in 1 mL ampoule	Injection	5	..	MX
Naloxone Hydrochloride	Injection 400 micrograms in 1 mL disposable injection set	Injection	1	..	CS
Injection 800 micrograms in 2 mL disposable injection set	Injection	1	..	CS
Injection 2 mg in 5 mL disposable injection set	Injection	1	..	CS
Naproxen	Tablet 250 mg	Oral	100	..	AF, RO
Tablet 500 mg	Oral	50	..	AF, RO
Tablet 750 mg (sustained release)	Oral	28	..	MD, RO
Tablet 1 g (sustained release)	Oral	28	..	MD, RO
Naproxen Sodium	Tablet 550 mg	Oral	50	..	MD, RO
Nitrazepam	Tablet 5 mg	Oral	25	..	AF, VT
Nystatin	Tablet 500,000 units	Oral	50	..	SI
Capsule 500,000 units	Oral	50	..	SI
Oral suspension 100,000 units per mL, 24 mL	Oral	1	..	BQ, SI
Oxazepam	Tablet 15 mg	Oral	25	..	AF, SI
Tablet 30 mg	Oral	25	..	AF, FM, SI
Oxycodone Hydrochloride	Tablet 5 mg	Oral	20	..	SI
Capsule 5 mg	Oral	20	..	MF
Capsule 10 mg	Oral	20	..	MF
Capsule 20 mg	Oral	20	..	MF
Oral solution 5 mg per 5 mL, 250 mL	Oral	1	..	MF
Tablet 5 mg (controlled release)	Oral	20	..	MF
Tablet 10 mg (controlled release)	Oral	20	..	MF
Tablet 20 mg (controlled release)	Oral	20	..	MF
Tablet 40 mg (controlled release)	Oral	20	..	MF
Tablet 80 mg (controlled release)	Oral	20	..	MF
Oxycodone Pectinate	Suppository equivalent to 30 mg oxycodone	Rectal	12	..	PL
Paracetamol	Tablet 500 mg	Oral	100	..	AW, DG, FM, HX, JT, PC, SW, TW
Oral liquid 120 mg per 5 mL, 100 mL	Oral	1	..	SW
Oral liquid 240 mg per 5 mL, 200 mL	Oral	1	..	SW
Pethidine Hydrochloride	Injection 50 mg in 1 mL ampoule	Injection	5	..	MX
Injection 100 mg in 2 mL ampoule	Injection	5	..	MX
Phenoxymethylpenicillin Benzathine	Oral suspension equivalent to 125 mg phenoxymethylpenicillin per 5 mL, 100 mL	Oral	2	..	FM, SI
Oral suspension equivalent to 250 mg phenoxymethylpenicillin per 5 mL, 100 mL	Oral	2	..	FM, SI
Phenoxymethylpenicillin Potassium	Tablet equivalent to 250 mg phenoxymethylpenicillin	Oral	50	..	SI
Tablet equivalent to 500 mg phenoxymethylpenicillin	Oral	50	..	SI
Capsule equivalent to 250 mg phenoxymethylpenicillin	Oral	50	..	CS, DP, FM, HX
Capsule equivalent to 500 mg phenoxymethylpenicillin	Oral	50	..	CS, DP, FM, HX
Piroxicam	Dispersible tablet 10 mg	Oral	50	..	AF, GX, HX, PF
Dispersible tablet 20 mg	Oral	25	..	AF, CH, GX, HX, PF, TW
Capsule 10 mg	Oral	50	..	AF, CH, GX, PF, TW
Capsule 20 mg	Oral	25	..	AF, CH, GX, PF, TW
Procaine Penicillin	Injection 1.5 g in disposable syringe	Injection	5	..	SI
Prochlorperazine	Suppositories 3 mg, equivalent to 5 mg prochlorperazine maleate, 5	Rectal	1	..	AV
Suppositories 15 mg, equivalent to 25 mg prochlorperazine maleate, 5	Rectal	1	..	AV
Prochlorperazine Maleate	Tablet 5 mg	Oral	25	..	AV, HP
Prochlorperazine Mesylate	Injection 12.5 mg in 1 mL ampoule	Injection	10	..	AV
Promethazine Hydrochloride	Injection 50 mg in 2 mL ampoule	Injection	10	..	MX
Sodium Chloride	I.V. infusion 154 mmol per L, 1 L	Injection	5	..	BX
I.V. infusion 513 mmol per L, 1 L	Injection	2	..	BX
Sodium Chloride with Glucose	I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L	Injection	5	..	BX
I.V. infusion 19 mmol-104 mmol (anhydrous) per 500 mL, 500 mL	Injection	5	..	BX
I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL, 500 mL	Injection	5	..	BX
Sulindac	Tablet 100 mg	Oral	100	..	AF
Tablet 200 mg	Oral	50	..	AF
Temazepam	Tablet 10 mg	Oral	25	..	AF, FM, SI
Tetanus Vaccine - Adsorbed	Injection 0.5 mL in pre-filled syringe	Injection	3	..	CS
Ticarcillin Sodium with Potassium Clavulanate	Powder for injection equivalent to 3 g ticarcillin-100 mg clavulanic acid	Injection	10	..	GK
Tramadol Hydrochloride	Capsule 50 mg	Oral	20	..	AW, CH, CS, GX, TW
Tablet 100 mg (sustained release)	Oral	20	..	AW, CS, HX
Tablet 150 mg (sustained release)	Oral	20	..	AW, CS, HX
Tablet 200 mg (sustained release)	Oral	20	..	AW, CS, HX
Oral drops 100 mg per mL, 10 mL	Oral	1	..	CS
Injection 100 mg in 2 mL ampoule	Injection	5	..	CS
Triamcinolone Acetonide	Injection 10 mg in 1 mL ampoule	Injection	5	..	BQ
Trimethoprim with Sulfamethoxazole	Tablet 80 mg-400 mg	Oral	10	..	AF, SI
Trimethoprim with Sulfamethoxazole	Tablet 160 mg-800 mg	Oral	10	..	AF, CH, GX, RO, SI, TW
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL	Oral	1	..	AF, RO, SI
Vancomycin Hydrochloride	Powder for injection equivalent to 500 mg (500,000 I.U.) vancomycin activity	Injection	2	..	LY, MX

Metronidazole	Tablet 400 mg	Treatment of anaerobic infections	Oral	21	..	AF, AV, HP
Paracetamol	Tablet 500 mg	Chronic arthropathies	Oral	300	..	AW, DG, FM, HX, JT, PC, SW, TW

Creams 100 g 1

Dusting Powders 100 g 1

Ear Drops 15 mL 2

Eye Drops containing Cocaine Hydrochloride BP 15 mL ..

Eye Drops, Other 15 mL 5

Eye Lotions 200 mL 2

Inhalations 50 mL 1

Linctuses containing Codeine Phosphate BP 100 mL ..

Linctuses, Other 100 mL 2

Lotions 200 mL 2

Mixtures containing Codeine Phosphate BP 200 mL ..

Mixtures, Other 200 mL 4

Mixtures for Children containing Codeine Phosphate BP 100 mL ..

Mixtures for Children, Other 100 mL 4

Mouth Washes 200 mL 1

Nasal Instillations 15 mL 2

Ointments and Waxes 100 g 1

Paints 25 mL 1

Pastes containing Cocaine Hydrochloride BP 25 g ..

Pastes, Other 100 g 1

Powders for Internal Use 100 g 2

Solutions 200 mL 2

Dated this twenty third day of November 2005.

JOAN CORBETT
Assistant Secretary
Pharmaceutical Benefits Branch
Department of Health and Ageing
Delegate of the Minister for Health and Ageing